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ABSTRACT 
Ion channels are transmembrane proteins that create a pathway for charged ions (sodium, 
potassium, calcium, and chloride) to pass through the otherwise impermeant lipid membranes. 
They are present both at the plasma membrane level and in the membrane of intracellular 
organelles. Ion channels engage in fundamental functions, such as muscle contraction, cell 
excitability, hormone secretion, mechanosensitivity, just to mention a few. Thus, the 
understanding of their physiology and pathophysiology remains an important task for science. 
This thesis embraces two projects involving two different ion channels: the Chloride Intracellular 
Channel 1 (CLIC1) and the large conductance Ca2+-voltage activated K+ channel (BK). 
The goal of the first project aimed to understand the role of CLIC1 channels in glioblastoma 
cancer stem cells. Among brain tumors, glioblastomas are very frequent and have the worst 
outcome. They are composed of two cell types: a small population of cells able to self-renew 
and generate progeny (cancer stem cells, CSCs) and a larger population possessing a limited 
division capacity and committed to a precise fate (bulk cells). Glioblastomas are very aggressive 
tumors because of CSC brain infiltration efficiency and their resistance to chemotherapies. 
Therefore, CSCs are the most tumorigenic component of glioblastomas and we have focused 
our efforts on this small population of cells. Several forms of glioblastomas show a high level of 
expression of CLIC1 compared to normal brains. CLIC1 is a protein mainly localized to the 
cytoplasm and nucleoplasm that is able to translocate to the plasma membrane and to the 
nuclear membrane where it acts as a Cl- channel. The soluble form of CLIC1 belongs to the 
glutathione S-transferase superfamily. Upon oxidation, the protein forms a dimer that 
translocates to the membrane and operates as an ion channel. Four human glioblastomas (all 
expressing CLIC1) have been studied. Human glioblastoma biopsies were cultured in a medium 
selecting for CSCs. By knocking down CLIC1 protein using siRNA viral infection (siCLIC1), we 
found that CLIC1-deficient cells migrated about 50% less efficiently than control cells treated 
with siRNA for luciferase (siLUC). Is this phenotype the result of CLIC1 absence in plasma 
membranes? To answer this question, we performed electrophysiological experiments from 
perforated patches for both siLUC and siCLIC1 cells. Cl- currents mediated by CLIC1 were 
isolated using a specific inhibitor (IAA94 100 μM). The results showed that siCLIC1 cells did not 
display IAA94-sensitive currents, while siLUC cells presented the CLIC1-mediated chloride 
current. Interestingly, in the four glioblastomas analyzed, there is a direct correlation between 
tumor aggressiveness and the relative abundance of IAA94 sensitive current: the more 
aggressive the tumor, the greater the relative abundance of CLIC1 current. These results point 
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to the view that CLIC1 is involved in glioblastoma CSCs migration. However, the mechanism 
has yet to be elucidated. 
The second project investigated the Ca2+-voltage dependent structural rearrangements of the 
human BK channel during its activation. BK channels are Ca2+-voltage-activated K+ channels. 
They are potent regulators of cellular excitability involved in processes such as neuronal firing, 
synaptic transmission, cochlear hair cell tuning and smooth muscle tone. The BK channel’s 
unique activation pathway is a consequence of its structurally distinct regulatory domains, 
including four transmembrane voltage sensors (VSD) and four pairs of intracellular Ca2+ 
sensors, RCK1 and RCK2 (Regulation of K+ Conductance). RCK1 includes residues D362/D367 
involved in high-affinity Ca2+ sensing, while RCK2 encompasses a stretch of five Asps (D894-
898 or Ca bowl) that coordinate Ca2+. In the functional tetrameric channel, the two RCK 
domains from each subunit assemble into a superstructure called the “gating ring”. To 
understand the allosteric interplay between these sensing apparata (VSD and RCK1/RCK2 in 
the gating ring), we have simultaneously tracked the conformational status of the VSD and the 
pore while activating the Ca2+ sensors in the gating ring by combining voltage clamp fluorometry 
with UV-photolysis of caged Ca2+. In WT channels, we found that the VSD conformational 
changes were triggered not only by voltage but also by [Ca2+] increase, demonstrating that Ca2+-
induced rearrangements of the BK intracellular gating ring allosterically propagate to the 
transmembrane VSD. The impairment of the Ca bowl in the RCK2 domain (D894-898N 
mutations) abolished the VSD facilitation induced by the rapid increase of [Ca2+]. However, the 
neutralization of the Ca2+ sensor in RCK1 (D362A/D367A mutations) did not prevent VSD 
facilitation by Ca2+ (as in WT channels, but to a lesser extent). Thus, RCK1 and RCK2 domains 
play different functional roles in the Ca2+-dependent activation of the human BK channel. A 
statistical-mechanical model has been implemented to quantify the thermodynamics of the 
functional coupling between intracellular and transmembrane regulatory domains in BK 
channels. This model includes one pore, four VSDs, four RCK1 Ca2+ sensors and four RCK2 
Ca2+ sensors. All these domains are regulated by equilibrium constants and linked by allosteric 
factors.  
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Figure 1. Scheme of the “cancer stem cell” (CSC) hypothesis. Tumors are heterogeneous 
and hierarchically organized. Upon dissociation and transplantation into an immuno-
compromised animal, human CSCs can reinitiate and grow a similar heterogeneous tumor in 
vivo (Baccelli and Trumpp, 2012).  
1.A INTRODUCTION 
Cancer Stem Cells 
‘‘The cancer stem cell hypothesis’’ states that both solid and liquid tumors are composed of i) a 
relatively small subset of slowly-cycling cells that undergo self-renewal for an unlimited period of 
time (cancer stem cells or CSCs) and ii) a larger population of cells committed to a precise fate 
and with finite division capacity (or bulk cells) (Reya et al., 2001). CSCs are defined, in analogy 
to normal stem cells, as cells that possess the capacity to self-renew and give rise to the variety 
of differentiated cells found in the malignancy (Vermeulen et al., 2008; Baccelli and Trumpp, 
2012). To date, the practical translation of this definition is the ability to generate a phenocopy of 
the original tumor in immuno-compromised mice (Figure 1). 
 
CSCs have been first identified in 1997 in human acute myeloid leukemia (Bonnet and Dick, 
1997). Bonnet and Dick found that some hematopoietic stem cells could undergo a tumorigenic 
event that in turn generated the acute myeloid leukemia. These stem cells not only are multi-
potent and able to self-renew but also possess cancer properties, such as karyotypic anomalies 
and unlimited proliferation ability (Huse and Holland, 2010). In the following years, it has been 
shown that different tumors contain CSCs, including brain tumors (Singh et al., 2004; Galli et al., 
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2004). Alike to neuronal stem cells, brain CSCs express stemness markers (as CD133), are 
localized in perivascular niches and grow as neurospheres in vitro (Huse and Holland, 2010; 
Calabrese et al., 2007; Jones and Holland, 2010; Charles and Holland, 2010; Stiles and 
Rowitch, 2008). 
The origin of CSCs remains controversial. These cells may derive from normal tissue stem cells. 
However, another possibility includes the introduction of oncogenes in committed progenitors 
that can give rise to malignant clones. For example, it has been shown that when ras and c-myc 
are introduced into oligodendrocyte progenitors, tumors with a glioblastoma multiforme 
phenotype arise upon in vivo transplantation (Barnett et al., 1998). This indicates that for tumors 
to occur there is no absolute prerequisite for genetic mutation of normal stem cells (Vermeulen 
et al., 2008).  
CSCs are difficult targets for cancer therapeutics because (1) they cycle slowly, (2) they express 
high levels of drug-export proteins (chemotherapy resistance), (3) the anti-apoptotic pathways of 
DNA repair are efficiently activated (radiotherapy resistance) and (4) they may not express the 
oncoproteins targeted by the new generation of drugs (chemotherapy resistance) (Stiles and 
Rowitch, 2008; Bao et al., 2006).  
Moreover, according to the CSC hypothesis, metastasis-initiating cells should be a subset of 
CSCs, since they are the cells capable of initiating and driving tumor growth and express 
migration markers (Baccelli and Trumpp, 2012). 
 
Glioblastoma Multiforme 
Gliomas are highly aggressive tumors of the central nervous system (CNS), originating from the 
neoplastic degeneration of glia cells, including astrocytes and oligodendrocytes (Sanai et al., 
2005; Huse and Holland, 2010; Chen et al., 2012). In the United States, about 80% of the CNS 
malignant tumors are gliomas, which are essentially incurable such that the overall 5-year 
survival rate remains less than 5% (CBTRUS, 2009).  
In general, cancer cells of origin are normal cells in which tumorigenic mutations first occur and 
accumulate to form a malignancy (Chen et al., 2012). In gliomas, astrocytes were thought to be 
the origin cells, as the only known replication-competent population (Figure 2). The malignant 
transformation process in this scenario requires a ‘‘dedifferentiation’’ process by which cells 
regain immature glial and progenitor properties. The recent discovery of neuronal stem cells 
(Reynolds and Weiss, 1992; Zhao et al., 2008) provided an alternative candidate for the glioma 
cell of origin (Figure 2). In neuronal stem cells, the oncogenic process can be viewed as losing 
control over their self-renewal and differentiation properties. 
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Figure 2. The origin of gliomas. Adult neural stem cells that undergo extensive mutations are 
sufficient to drive malignant glioma formation in vivo. Also, progenitors or mature astrocytes 
are found as cells of origin (Chen et al., 2012).  
 
The World Health Organization has classified gliomas in four groups (grade I-IV) based on their 
histology, pleomorphism, localization and expression pattern: the higher the grade the worst the 
prognosis (Maher et al., 2001; Huse and Holland, 2010; Denysenko et al., 2010). Thus, the 
most aggressive glioma is the grade IV, or glioblastoma multiforme (GBM), which is 
characterized by unlimited proliferation ability, neovascularization, infiltration and necrosis. 
Unfortunately, the occurrence of the GBM is more frequent than all the other glioma types, as 
reported in Figure 3 (Jones and Holland, 2010).The life expectancy for patients diagnosed with 
GBM is between 12 and 15 month (Chamberlain, 2010; Maher et al., 2001). The reason for this 
poor prognosis mainly resides in the fact that GBMs are resistant to radiotherapy and 
chemotherapy. Moreover, due to its high invasiveness in the brain tissue, surgery is normally 
not successful and the tumor relapses within a few months (Lefranc et al., 2005).  
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GBMs are characterized by an extensive angiogenesis. The new blood vessels favor tumor 
growth and infiltration by providing oxygen and nutrients to tumor cells (Denysenko et al., 2010; 
Sanai et al., 2005; Jones and Holland, 2010). Furthermore, blood vessels and white matter offer 
a support along which tumor cells invade the brain tissue (Furnari et al., 2007; Sanai et al., 
2005; Vescovi et al., 2006). Differently from the other solid tumors, gliomas do not take 
advantage of the linfantic and blood streams to spread and form metastasis outside of the CNS 
(Maher et al., 2001). 
To explain how GBMs initiate and develop, to date two alternative models are present (Figure 
4). The stochastic model proposes that tumor cells are heterogeneous, and virtually all of them 
can function as a tumour-founding cell. On the other hand, the hierarchical model implies that 
only a small subpopulation of tumour stem cells can proliferate extensively and sustain the 
growth and progression of a neoplastic clone (Vescovi et al., 2006). The latter hypothesis fits 
with the cancer-stem-cell theory. 
 
 
 
 
 
 
 
Figure 3. The plot shows the frequency of new primary gliomas in USA between 2004 
and 2006. The glioblastoma represents more than 50% of all the gliomas (CBTRUS 
2010). 
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Figure 4. Tumor initiation models. (A) The stochastic model predicts that all the cells in a 
tumor have a similar tumorigenic potential, which is activated asynchronously and at a low 
frequency. (B) The hierarchical model predicts that only a rare subset of cells within the 
tumor (CSC) has significant proliferation capacity and the ability to generate new tumors 
(Reya et al., 2001). 
 
Ion channels and tumor migration 
Ion channels are transmembrane proteins responsible for the passive exchange of ions across 
the plasmamembrane and the other membranes in the cell. There are many types of ion 
channels, which at the functional level are traditionally classified by either the stimulus that 
gates them or the ion species that they pass. Ion channels are involved in all the fundamental 
cellular processes, such as cell cycle, differentiation, homeostasis and apoptosis (Kunzelmann, 
2005; Wonderlin and Strobl, 1996; Prevarskaya et al., 2010). They also play an important role in 
tumors. The involvement of different types of ion channels has been shown in defining each of 
the six cancer hallmarks: 1) self-sufficiency in growth signals, 2) insensitivity to antigrowth 
signals, 3) avoidance of programmed cell death (apoptosis), 4) unlimited replicative potential, 5) 
angiogenesis and 6) tissue invasion and metastasis (Figure 5) (Prevarskaya et al., 2010; Fraser 
and Pardo, 2008). 
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Figure 5. Different types of ion channels are involved in each of the six cancer hallmarks 
(Fraser and Pardo, 2008). 
 
 
Specifically, tissue invasion and metastasis involve cell migration, which consists of common 
mechanisms both in physiological and pathological processes (Schwab, 2001; Friedl and 
Gilmour, 2009; Schwab et al., 2012). Migrating cells are polarized and move along a front-to-
back axis. Migration engages a repeated cycle of protrusion of lamellipodia/invadipodia, 
cylindrical extroflections that provide the forward movement of the cell, and retraction of the rear 
part of the cell. The polarization of migrating cells also comprises the subcellular distribution of 
membrane proteins such as chemokine receptors and transport proteins as well as the 
composition of the plasma membrane itself (Schwab, 2001; Lefranc et al., 2005; Schwab et al., 
2012). In particular, ion channels facilitate migration by conducting ions towards the extracellular 
milieu, leading to the osmotic movement of water. Thus, ion channels are able to efficiently 
regulate global cell volume or create local osmotic gradients facilitating the swelling or shrinking 
of cellular processes (Figure 6) (Cuddapah and Sontheimer, 2011). 
As anticipated, cell migration is critical to cancer metastasis and malignant progression. In 
gliomas, cells move from the tumor central mass to adjacent parenchyma by migrating through 
the narrow extracellular space. This is facilitated by the overexpression of ion channels involved 
in cytoplasmic volume regulation, mainly K+ channels and Cl- channels that concomitantly 
release K+ and Cl- ions, leading to the osmotic release of water. This in turn leads to 
cytoplasmic volume decrease, allowing cells to squeeze through narrow extracellular spaces. It 
has been recently shown that invading glioma cells decrease their volume by 30 –35% 
(Cuddapah and Sontheimer, 2011; Watkins and Sontheimer, 2011). This percentage resembles 
the maximally achievable cellular volume decrease, suggesting that invading cells secrete all 
free, unbound cytoplasmic water to maximize their chance of crossing narrow barriers. 
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Figure 6. Cell volume rearrangements during cell migration. Cell migration consists of a 
continuous cycle of protrusion of the cell front (top) and retraction of the trailing end (bottom). 
This can be modeled as a localized volume increase at the cell front and volume decrease at 
the rear end, involving mainly K+ and Cl- conductances and aquaporins. The disassembly of 
focal adhesion components at the rear part of migrating cells involves the Ca2+ -sensitive 
family of calpain proteases (Schwab et al., 2012). 
Moreover, exchangers like the Na+/H+ exchanger facilitate malignant cell invasion by acidifying 
the extracellular space to digest the extracellular matrix (Cuddapah and Sontheimer, 2011).  
 
Glioblastoma cells maintain high intracellular Cl- (80–100 mM), similar to immature neurons 
(Habela et al., 2009; Sontheimer, 2008). Thus, even at a relatively depolarized resting potential 
(~ -40 mV), opening of Cl- channels causes Cl- efflux. The high intracellular [Cl-] is accomplished 
by the activity of the Na+/K+/Cl- co-transporter, which is highly expressed in invadipodia of 
glioblastoma cells (Haas and Sontheimer, 2010).  
The most relevant channels expressed in glioblastoma are: 
- a splice variant of the Ca2+- and voltage- activated K+ (BK) channel named gBK; it  contains a 
34 amino acid insert near the Ca2+ sensor of the channel that increases Ca2+ sensitivity (Liu et 
al., 2002);  
- acid-sensing Na+ channels (ASIC) (Berdiev et al., 2003); 
- ClC-2 and ClC-3 Cl- channels; ClC-3 channels localize to the same specialized lipid domains 
on the invadipodia that also contain gBK channels (Sontheimer, 2008); 
- the water channel aquaporin-4, also contained in the same lipid raft domains as gBK and ClC-
3 (McCoy and Sontheimer, 2007). 
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Figure 7. CLIC1 crystal structure. (A) The monomeric structure of CLIC1 in the soluble, 
reduced form (α-helices in red, β-strands in yellow, loops in green). The putative TM region 
is in cyan (residues 25–46). (B) The crystal structure of the oxidized CLIC1 dimer: the left 
subunit is colored yellow, while the right subunit is colored and oriented as the CLIC1 
monomer in panel A. The four-stranded mixed β-sheets that are characteristic of the 
thioredoxin fold transformed into α-helices and loops (Littler et al., 2010).  
The chloride intracellular channel 1 (CLIC1) 
In the late ‘80, the first Chloride Intracellular Channel (CLIC) protein, p64 (now known as 
CLIC5b), was isolated from bovine tracheal apical epithelium and kidney cortex microsomal 
membrane fractions (Landry et al., 1993; Redhead et al., 1992). 
The CLIC family possesses six known members (CLIC1-6) with differential tissue distribution 
and function both in the plasmamembrane and intracellular organelles. They share structural 
homology with members of the omega glutathione S-transferase (GST) superfamily (Singh, 
2010; Littler et al., 2010; Averaimo et al., 2010; Edwards and Kahl, 2010). A unique feature of 
CLIC proteins is their ability to exist in two different forms: a soluble globular form and an 
integral membrane protein, suggested forming functional ion channels. However, the presence 
of a single putative transmembrane domain has led to doubt over their ability to function as ion 
channels (Duran et al., 2010; Jentsch et al., 2002).  
CLIC1 was cloned in 1997 from a human monocytic cell line and localized in the cell nucleus 
and cytoplasmic organelles (Valenzuela et al., 1997). This protein adopts at least two stable 
tertiary structures, with redox status controlling the transition between them thus making CLIC1 
a member of the rare category of ‘‘metamorphic proteins” (Murzin, 2008; Littler et al., 2010). In 
fact, it has been shown that the effect of oxidation on CLIC1 allows the protein to undergo a 
reversible transition between a reduced, soluble monomeric state and an oxidized, soluble 
dimeric state (Figure 7) (Littler et al., 2004). The non-covalent dimer interface comprises a flat, 
hydrophobic surface that could favor the protein insertion into a lipid bilayer. Thus, the half 
dimer structure may represent the membrane docking form of CLIC1 (Littler et al., 2004).  
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However, a different study suggests that the dimerization process during oxidation is not 
necessary for the insertion of the protein into membranes (Goodchild et al., 2009). In this model, 
CLIC1 monomer interacts by itself with the membrane surface and successively the oxidation 
promotes the structural changes that allow the protein to cross the membrane.  
The ion channel activity of CLIC1 has been characterized in both cells and artificial bilayers. The 
first evidence of a CLIC1-mediated current was shown in CLIC1 transfected CHO-K1 cells 
through cell and nuclear patch clamp (Tonini et al., 2000). By transfecting these cells with 
CLIC1 bearing either a N- or C-terminal FLAG epitope tag and using an antibody anti-FLAG, it 
was demonstrated that CLIC1 spans the plasma membrane an odd number of times with the C-
terminus in the cytoplasm (Tonini et al., 2000). Further electrophysiological studies in CHO-K1 
cells indicate that CLIC1 chloride current varies according to the stage of the cell cycle, being 
expressed only on the plasma membrane of cells in G2/M phase (Valenzuela et al., 2000). In 
addition, the purified CLIC1 protein has been functionally reconstituted in artificial bilayer by 
different laboratories (Warton et al., 2002; Singh et al., 2007; Tulk et al., 2002) to show that 
CLIC1 forms functional ion channels in the absence of ancillary protein. The main single 
channel conductance in 140 mM KCl symmetric solution is approximately 30 pS (Tulk et al., 
2002; Warton et al., 2002).  The only effective channel blocker so far identified is the 
Indanyloxyacetic acid 94 (IAA94), with an EC50 of 8.6 μM (Tulk et al., 2000). To further support 
the ion channel nature of CLIC1, it has been reported that a single point mutation (C24A) in 
CLIC1 putative transmembrane region results in alterations of the electrophysiological 
characteristics of the channel (Singh and Ashley, 2006).  
CLIC1 is widely expressed in epithelial and non-epithelial cell types where it shows tissue- and 
cell-specific patterns of subcellular localization (Ulmasov et al., 2007). However, CLIC1 
physiological function is not fully understood. Several studies address the question of CLIC1 
function. The human gene is located within the major histocompatibility complex class III region, 
one of the most conserved and important regions in the genome. It has been recently generated 
a Clic1 KO mouse that does not show any embryonic lethality but only a mild bleeding disorder 
and decreased platelet activation (Qiu et al., 2010). Different lines of evidence support the 
hypothesis of a fundamental role of CLIC1 protein in activated microglia. For example, CLIC1 
expression increases by 60% in the hippocampus of mild/moderate Alzheimer patients  
(Parachikova et al., 2007). Moreover, in a mouse model of Alzheimer disease, CLIC1 is mainly 
localized in the plasma membrane of activated microglia (Figure 8) (Milton et al., 2008). The 
blockade of CLIC1 functional expression with specific inhibitors or its downregulation by small 
interference RNA impairs the production of reactive oxygen species, limiting the detrimental 
effects of microglia over activation (Milton et al., 2008; Novarino et al., 2004). In these 
conditions, neurodegeneration may be limited without affecting the phagocytic ability of 
microglia (Paradisi et al., 2008). 
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Figure 8. CLIC1 subcellular localization. Immunolocalization of CLIC1 (green, antibody 
directed against the N-terminus of the protein) in BV2 cells (nuclei are stained in blue, DAPI). 
Following b-Amyloid (Ab) stimulation, which induces oxidative stress, CLIC1 translocates 
into the plasma membrane (Milton et al., 2008).  
AβControl 20 m
 
CLIC1 in tumors 
CLIC1 appears to have a main role in all the diseases that involve oxidative stress, including 
tumors (Averaimo et al., 2010). As reported above, CLIC1 is detected on the plasma membrane 
of cells in the G2/M phase of the cell cycle (Valenzuela et al., 2000). During this phase, the 
current density is  approximately twice the one recorded in the G1/S phase. Moreover, CLIC1 
blockade prolongs the average duration of the cell cycle. Since oxidative fluctuations drive the 
cells through the cell cycle phases (Menon and Goswami, 2007), it is not surprising that CLIC1 
may be very active as an ion channel in cancer cells, which are cells in a highly proliferative 
state. 
It has been shown that CLIC1 plays a role in a variety of human solid tumors such as human 
gastric carcinoma (Chen et al., 2007), colorectal cancer (Petrova et al., 2008), gallbladder 
carcinoma (Wang et al., 2009), hepatocarcinoma (Li et al., 2012) and glioma (Kang and Kang, 
2008; Wang et al., 2012). In this latter case, data from Oncomine (oncomine.com) show that 
CLIC1 is overexpressed in brains from glioblastoma patients compared to patients with no 
tumor (Figure 9). Furthermore, it has been recently reported that CLIC1 expression at both 
mRNA and protein levels is increased in high-grade (Grade III~IV) glioma tissues compared 
with that in low-grade (Grade I~II) (Wang et al., 2012). 
This thesis project focuses on the role of CLIC1 in human glioblastomas, and specifically in the 
subpopulation of cells that are most likely responsible for tumor infiltration and so far resistant to 
therapies: the cancer stem cells. 
14 
 
 
Figure 9. CLIC1 is overexpressed in glioblastomas. The figure shows the RNA 
expression profile on arrays for CLIC1 in a subset of 81 glioblastomas and 23 non-
tumoral tissues.  
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Figure 10.    Human brain tumor biopsys were dissociated and cultured in a specific medium 
that allows only CSCs to grow (no serum, plus EGF and FGF) (Vescovi et al., 2006). 
Figure 11. Neurospheres 
from glioblastoma CSCs are 
grown in suspension in a 
serum-free medium. 
50 m
1.B METHODS 
Tumor sample preparation 
Tumor specimens classified as GBM were collected from consenting patients at the Istituto 
Neurologico Carlo Besta, Department of Neurosurgery, Milan (Italy). Tissues were enzymatically 
processed with papain (2mg/ml) (Worthington Biochemical, Lakewood, NJ) at 37°C and 
mechanically dissociated until a single cell suspension was achievement (Figure 10). 
 
Cell culture 
Cancer stem/progenitor cells were grown in suspension as 
spheroid aggregates (neurospheres), each deriving from a 
single cancer stem cell (Figure 11). The neurosphere assay 
is a defined serum-free culture system that allows the 
isolation and propagation of CNS-derived stem cells. Adult 
precursors from human GBM were dissociated and plated in 
NeuroCult medium (StemCell Technologies, Vancouver, BC, 
Canada) supplemented with 20 ng/ml epidermal growth 
factor (EGF), 10 ng/ml basic fibroblast growth factor (bFGF) 
(PeproTech, Rocky Hill, NJ), and 0.0002% heparin (Sigma-
Aldrich, St. Louis, MO)(Ortensi et al., 2012). Because of the 
lack of serum and the low plating density (~100 cells/cm2), 
differentiated cells die, while cells that divide in response to 
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Figure 12. Scheme of non-replicating lentiviral vector for stable shRNA expression. Host 
cells (293T cells) are transfected with a mixture of plasmids: i) an shRNA expression 
cassette, ii) a packaging cassette and iii) a heterologous viral envelope expression cassette. 
The generated lentivirus is then used to transduce the desired cell type for shRNA 
expression. Because only the vector containing the shRNA expression cassette integrates 
into the host cell genome in the transduced cells, shRNA is continually expressed but 
infectious virus is not produced (Manjunath et al., 2009).  
the stem-cell mitogens survive. The growth-factor-responsive cells proliferate to form floating 
clusters of cells that are referred to as neurospheres. These can be further mechanically 
dissociated into a single-cell suspension and then re-plated in fresh medium to produce 
secondary neurospheres every 5-10 days. The process can be repeated, resulting in a 
geometric expansion in the number of cells that are generated at each passage (Figure 10) 
(Vescovi et al., 2006).  
 
Lentiviral infection  
RNA interference (RNAi) was first recognized as a natural antiviral defense mechanism in plants 
wherein long double-stranded RNAs are cleaved into short 21–23 nucleotide double-stranded 
RNA molecules called small interfering RNAs (siRNAs) that mediate sequence-specific gene 
silencing. Experimentally, RNAi can be induced by the direct introduction of synthetic siRNA into 
the cells or by intracellular generation of siRNA from vector driven expression of the precursor 
small hairpin (sh) RNAs (Figure 12) (Manjunath et al., 2009). In the latter method, a double-
stranded oligonucleotide containing the siRNA sequence linked by a ~9 nucleotide loop is 
cloned in plasmid or viral vectors to endogenously express shRNA which is subsequently 
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processed in the cytoplasm to siRNA. Lentiviruses may be particularly suited for long-term 
shRNA expression and gene silencing since the viral DNA gets incorporated in the host 
genome. 
Short hairpins specific to human CLIC1 (5’-GATGATGAGGAGATCGAGCTC-3’) and to firefly 
luciferase (5’-CGTACGCGGAATACTTCGA-3’) mRNAs were cloned into the PLentiLox 3.7 
lentiviral vector using the XhoI/HpaI sites. The PLentiLox 3.7 lentiviral vector also includes the 
puromycine gene to select infected cells and the Green Fluorescent Protein (GFP) gene to 
evaluate transduction efficiency. Lentiviral and packaging plasmids (vpMDLg/pRRE, pRSV-REV 
and pMD2G) were amplified in the E.Coli-strain Top10 and purified using a QUIAGEN MAXI 
KIT. HEK 293T cells were used to amplify the viral particles and they were grown in IMDM 
(Iscove’s Modified Dulbecco’s Medium, plus Glutamax, Invitrogen) with 10% FBS and 25 U/ml 
Penicillin/Streptomycin. HEK 293T cells were co-trasfected with all the plasmids using the 
calcium phosphate method according to established procedures (TronoLab). The viral particles 
were collected and concentrated using PEG-it. The transducing unit (TU) concentration was 
then determined by GFP expression. The viral suspension was used to infect dissociated CSCs 
from human GBM (104 TU/µl). 72 hours after infection, cells were positively selected with 1.5 
mg/ml puromycine.  
 
Western Blot 
Western blot analysis uses denaturating gel electrophoresis to separate proteins by their size; 
the proteins are then transferred to a membrane (typically nitrocellulose or PVDF), where they 
are immunostained with specific antibodies. This technique was used to evaluate the 
interference efficiency 72 hours after selection with puromycine. Neurosphere samples were 
collected by centrifugation and pellets were lysated  on ice in 50-100 µl of lysis buffer (50 mM 
Tris–Cl buffer, 10 mM CaCl2, 5mM EGTA, 250 mM NaCl , 10% Glycerol, 1% triton-x 100, pH 8) 
containing a cocktail of proteinase inhibitors (50 mM NAF, 10 mM NAPP, 10mM NaOrtoV, 
0.1mg/ml PMSF, Leupeptin , Apoprotinin ). Concentration of protein lysates was assessed by 
Bradford assay (Biorad). Each lysate (10 µg) was loaded onto a SDS-polyacrylamide gel 
electrophoresis (PAGE) under reducing conditions, and resolved proteins were transferred onto 
Nitrocellulose membranes (Protran ®) of 0.2 μm pore size. Membranes were incubated 
overnight at 4°C with anti-CLIC1 mouse monoclonal antibody and anti-Vinculin diluted in Tris-
Buffered Saline and Tween 20 (TBS-T [50mM Tris, 150mM NaCl, 0.05% Tween 20]) 
supplemented with 5% Milk Powder. Antibody binding was assessed by horseradish peroxidase 
(HRP)-conjugated secondary antibody (Sigma Aldrich, 1:10000 dilution). Immunoreactive bands 
were detected with enhanced chemiluminescence reagents (GE Healthcare Bio-Sciences). 
 
Boyden chamber assay 
The Boyden chamber is a useful tool to study cell migration. It consists of two chambers 
separated by a filter that was originally constructed by Boyden (BOYDEN, 1962) Cells are 
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Figure 13. Schematic drawing of a Boyden Chamber. 
Cells are seed in the upper chamber, while in the bottom 
chamber there are the chemoattractants agents (EGF, 
FGF). After 48h, cell migration ability through the porous 
filter (8 µm diameter) into the lower chamber is assessed. 
Porous filters
EGF, FGF Invading cells
48h
Figure 14. Schematic diagrams showing a pipette pressed 
against the cell membrane (left), and after formation of a 
gigaseal when a small patch of membrane is drawn into the 
pipette tip (right) (Hamill et al., 1981).
placed into the upper chamber, while the chemotactic substance is added into the lower one. 
The size of the motile cells to be investigated determines the pore size of the filter (Figure 13). 
To assess the migration 
efficiency of glioblastoma CSCs, 
50,000-100,000 cells were 
seeded in the upper chamber in 
100 µl of growth factor-free 
medium, while the lower chamber 
was filled with 600 µl of EGF-
FGF supplemented medium as 
chemoattractants (Figure 13). 
After 48-72h transwells were 
removed and stained with crystal 
violet solution for 10 minutes and 
then thoroughly washed with 
water. Crystals were solubilized 
in 10% acetic acid solution and 
quantified by absorbance (λ=600 
nm). 
 
Patch clamp 
The patch clamp technique 
allows to measure the ionic 
currents passing through ion 
channels (Neher and 
Sakmann, 1992; Neher and 
Sakmann, 1976; Sakmann 
and Neher, 1984). In this 
technique a small heat-
polished glass pipette is 
pressed against the cell 
membrane where the ion 
channels are embedded and 
forms an electrical seal with a 
resistance of ~1-10 GΩ 
(Figure 14) (Hamill et al., 
1981). The high resistance of the seal ensures that most of the currents originating in a small 
patch of membrane flow into the pipette, and from there into current-measurement circuitry. An 
electrode (a silver wire coated with AgCl), located inside the glass pipette and connected to the 
circuitry, converts the ionic current into electrical current. This configuration is defined as cell-
19 
 
 
Figure 15. Comparing the conventional whole cell patch-clamp configuration (left) and the 
perforated patch technique (right), it is evident that the advantage of the latter is to preserve 
the intracellular milieu. In perforated patch, the electrical access to the cell is achieved 
taking advantage of the pore forming ability of certain antibiotics (such as gramicidin). 
Gramicidin    
Gramicidin pore    
attached. Other possible configurations are (Hamill et al., 1981; Neher and Sakmann, 1992; 
Horn and Patlak, 1980): 
- inside-out configuration, where the pipette is rapidly withdrawed from the cell-attached 
configuration without destroying the giga-seal, leaving a cell-free membrane and allowing 
current recordings in known intracellular solutions;  
- whole-cell configuration, where after giga-seal formation the membrane patch is disrupted  
providing a direct low resistance access to the cell interior allowing for recordings from the ion 
channels in the whole cell membrane (Figure 15); 
- outside-out configuration, where the pipette is gently withdrawed from the whole-cell 
configuration without destroying the  giga-seal, leaving a cell-free membrane patch exposing in 
the bath solution the outer leaflet of the lipid bilayer; 
- perforated patch, where the pipette contains specific antibiotics (such as gramicidin, 
anphotericin B or nystatin) that, once inserted in the plasmamembrane, provide electrical 
access to the cell interior preserving the cytoplasm content (Figure 15). 
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Detailed protocol for the patch clamp experiments reported in this thesis: Cancer stem cells 
from human glioblastomas primary cultures (h70.01.42, hGBMR1, h60.90.12 and h60.50.51) 
were voltage-clamped using an Axopatch 200 B amplifier (Molecular Devices) in the perforated 
patch configuration. Ionic currents were digitized at 5 kHz and filtered at 1 kHz. The bath 
solution (mM) contained: 130 NMDG-Cl, 2 MgCl2, 2 CaCl2, 10 HEPES, 10 Glucose, 5 TEA-Cl 
(pH=7.4). The pipette solution was (mM): 145 KCl, 1 MgCl2, 10 HEPES (pH=7.25); prior 
experiments, 2.5 µg/ml Gramicidin (Sigma) was added to the solution. Gramicidin is an 
antibiotics capable to insert into plasma membranes and form pores permeable only to 
monovalent cations, allowing to gain electrical access to the cell as well as preserve the [Cl-]i 
and the cytoplasm content. The voltage protocol consisted of 800 ms pulses from -80 mV to +80 
mV (20 mV voltage steps); the holding potential was set according to the resting potential of the 
cell (between -40 and -80 mV). CLIC1-mediated Cl- currents were isolated from the other ionic 
currents in the cells by perfusing a specific inhibitor (Indanyloxyacetic acid 94, IAA94 100 μM) 
dissolved in the bath solution using a Rapid Solution Changer (RSC-200, BioLogic). Other Cl- 
currents were isolated using the aspecific inhibitor DIDS 200 μM (Disodium 4,4′-
diisothiocyanatostilbene-2,2′-disulfonate).  
Analysis: Offline analysis was performed using Clampfit 9.0 (Molecular Devices), OriginPro 8.5 
and Excel routines. IAA94-sensitive (IIAA94) and DIDS-sensitive (IDIDS) currents were estimated 
by analytical subtraction of ionic currents after addition of either inhibitor from the total current 
(ITOT) of the cell at each membrane potential tested. Current/Voltage relationships (or I/V curves) 
were constructed by plotting the averaged ionic current data points in the last 100 ms of the 
pulse against the corresponding membrane potential. IAA94-sensitive and DIDS-sensitive 
currents were normalized to the total ionic current of the cell (IIAA94/ITOT and IIAA94/ITOT, 
respectively); IIAA94/ITOT% and IIAA94/ITOT% from the same cell types were averaged and plotted 
against the membrane potential. Error bars are the standard error of the mean in all plots. 
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Figure 16. CLIC1 expression in four human glioblastomas. Neurospheres from the four 
different tumors were lysed and assessed for CLIC1 expression by western blot analysis. 
CLIC1 band is detectable in al the tumors analyzed.  
1.C RESULTS 
This study aimed to investigate the role of CLIC1 protein in cancer stem cells (CSCs) from 
human glioblastoma to ultimately understand new mechanistic information about tumor 
invasiveness. In particular, our attention was focused on CLIC1 fraction in the plasmamembrane 
in that it would eventually result in a more accessible therapeutic target. 
 
Knock-down of CLIC1 expression in human glioblastoma CSCs 
The early stages of this project have been developed in Dr Pelicci laboratory, our collaborator at 
the European Institute of Oncology. They established primary cultures of CSCs from four 
different human glioblastomas (h70.01.42, hGBMR1, h60.90.12 and h60.50.51). In the 
appropriate medium, CSCs grow as neurospheres in suspension and they can be propagated in 
culture by mechanical dissociation, following the method implemented by Vescovi and 
colleagues (Vescovi et al., 2006).  
CLIC1 expression was explored in these four glioblastomas. Western blot analysis was 
performed on neuropsheres lysates, showing that all the tumors expressed CLIC1 (Figure 16). 
 
In order to study CLIC1 role in CSCs from glioblastoma, the strategy applied was to knock-down 
its expression level taking advantage of the RNA interference (RNAi) technique. A lentiviral 
vectors carrying the shRNA (short hairpin RNA) against human CLIC1 (siCLIC1) or against the 
firefly luciferase (siLuc) were engineered and transduced into CSCs from h70.01.42 and 
hGBMR1 tumors. To verify the extent of CLIC1 silencing in the different glioblastomas, a 
western blot was performed on both the infected cells and the control cells (no infection). By 
probing the membrane with antibodies anti-CLIC1 and anti-Vinculin, we found that CLIC1 
protein expression was reduced in both tumors (Figure 17A). Densitometry analysis revealed 
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Figure 17. Efficiency of CLIC1 silencing in CSC from human glioblastomas. (A) Western 
blot analysis was performed on whole lysates from siLUC, siCLIC1 and not-infected cells 
and probed with anti-CLIC1 and anti-Vinculin antibodies. (B) Histograms show the 
normalization of CLIC1 signal to Vinculin signal: the reduction of CLIC1 protein in siCLIC1 
cells is about 50% in both patients compared to siLUC and not-infected cells. 
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that the efficiency of CLIC1 silencing was 60% in h70.01.42 cells and 50% in hGBMR1 cells 
(Figure 17B). 
 
CLIC1 silencing decreases migration ability of glioblastoma CSCs 
Since glioblastomas are highly invasive tumors, we asked whether the silencing of CLIC1 –a Cl- 
channel- could impact on the ability of CSCs to migrate. 
The migration assay was performed using the Boyden chambers, two chambers separated by a 
porous filter (8 µm pore diameter). 100,000 siCLIC1 or siLUC CSCs were seeded in the top 
chamber in a growth-factor-free medium. Chemoattractants factors (FGF, EGF) were added in 
the bottom chamber to stimulate CSCs to migrate through the filter pores. After 48h the cells 
that reached the bottom chamber were fixed and stained with Crystal violet. The quantification 
was achieved by measuring the absorbance (A) at λ = 600 nm with a spectrophotometer (Figure 
18). In the h70.01.42 tumor, we found that in the siLUC cells A was 0.49 + 0.08 (n = 3), while in 
the siCLIC1 cells A was reduced to 0.29 + 0.08 (n = 3). Similar results were obtained for the 
hGBMR1 tumor: in the siLUC cells A was 0.99 + 0.34 (n = 4) and in the siCLIC1 cells A 
decreased to 0.50 + 0.29 (n = 4). The student’s t-test showed that the reduced migration ability 
of the cells partially lacking CLIC1 was significant (p < 0.05). 
Taken together, these data show that the migration efficiency of CSCs from two different human 
glioblastomas was reduced when CLIC1 was silenced.  
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Figure 18. CLIC1 silencing decreases migration ability of glioblastoma CSCs. The 
histograms represent the average absorbance (λ= 600 nm) for h70.01.42 (n=3) or hGBMR1 
(n=4) siCLIC1 and siLUC cells following Boyden chamber assay. 
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siRNA against CLIC1 abolishes CLIC1-mediated currents in 
glioblastoma CSCs 
As we stated above, CLIC1 possesses at least two stable conformations: one in the cytoplasm 
and one in the lipid bilayer. We asked whether CLIC1 as an ion channel was responsible for the 
decreased migration efficiency of CSCs or its soluble counterpart.  
To address this question, we took advantage of the patch clamp, a very powerful technique to 
measure ionic conductances in cells. Specifically, we used the perforated patch clamp 
technique, which differs from the classical whole-cell configuration in that after gigaseal 
formation there is no suction to rupture the patch membrane. Instead, the electrode solution 
contains antibiotics that, by inserting into the membrane, provide electrical access to the cell 
interior. In the experiments presented here, we used gramicidin, which forms pores permeable 
only to monovalent cations. This has the advantage of reducing the dialysis of the cell: in 
particular the intracellular [Cl-] and the soluble CLIC1 are preserved inside the cell.  
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In a typical experiment, after gigaseal formation, it took 10-20 minute for the gramicidin to insert 
into the plasmamembrane; this was ascertained by monitoring the capacitive current increase 
and the resting potential stabilization. The resting potential could vary between -30 mV and -80 
mV and the holding potential of each experiment was set according to the resting potential of 
that specific cell. Once the gramicidin is inserted in the membrane, bath solution, 100 μM IAA94 
(CLIC1 inhibitors) and 100 μM IAA94 + 200 μM DIDS (Cl- channels inhibitor that does not affect 
CLIC1 current) were sequentially perfused on the cell and ionic currents were recorded at 
different imposed membrane potentials. By analytical subtraction IAA94- and DIDS-sensitive 
currents were isolated from the total current of the cell (Itot). Since the absolute values of these 
currents were different from cell to cell, they were normalized to Itot obtaining the percentage of 
IAA94-sensitve current (% IIAA94) and DIDS-sensitive current (% IDIDS) (also see methods for 
more details). 
In Figure 19, perforated patch experiments are shown for cells from the patient h70.01.42: not 
infected cells and siLuc or siCLIC1 cells. The IAA94-sensitve current was detectable in both not 
infected and siLuc cells, while it was absent in the siCLIC1 cells (Figure 19A). The 
Current/Voltage relationships clearly show the lack of IAA94-sensitive current in siCLIC1 cells 
(Figure 19B). For example, at 20 mV % IIAA94 was 24.55% + 6.6% (n = 6), 16.72% + 3.21% (n = 
8) and -0.76% + 2.04% (n = 7) in not infected, siLuc and siCLIC1 cells respectively. These 
results strongly suggest that CLIC1 silencing affects the proteins in the plasmamembrane. On 
the other hand, DIDS-sensitive currents were recorded from all the groups of cells: at +20 mV % 
IDIDS was 38.67% + 9.93% (n = 6) in not infected cells, 35.33% + 5.44% (n = 8) in siLUC cells 
and 37.43% + 6.20% (n = 4) in siCLIC1 cells (Figure 21). 
The experimental observations from cells of the hGBMR1 tumor provided qualitatively similar 
results to data from h70.01.42 cells (Figure 20). In siCLIC1 cells, IAA94-sensitve current was 
abolished by silencing CLIC1 protein, unlike DIDS-sensitive current that were recorded from all 
cell groups. For example, at 20 mV % IIAA94 was 21.75% + 3.91% (n = 5), 28.05% + 3.97% (n = 
7) and 2.38% + 0.91% (n = 5) in not infected, siLuc and siCLIC1 cells respectively; while IDIDS 
was 23.88% + 4.63% (n = 5) in not infected cells, 21.09% + 5.65% (n = 4) in siLUC cells and 
28.45% + 13.05% (n = 3) in siCLIC1 cells (Figure 21). 
Averaging all the experiments performed at each membrane potential, we found that, in both 
tumors, siCLIC cells displayed a complete abolishment of the CLIC1-mediated current, while the 
DIDS-sensitive current were unaltered, underlying the specificity of siRNA effect (Figure 21). 
Overall, the results from h70.01.42 and hGBMR1 cells support the view that CLIC1 silencing 
affects both CLIC1 expression and ion channel activity, revealed as the lack of IAA94-sensitive 
current in CLIC1 silenced cells. 
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Figure 19. siRNA abolishes CLIC1 currents in h70.01.42 CSCs.  (A) Rapresentative ionic 
current traces from perforated patches of CSCs from h70.01.42 tumors (not infected, siLuc 
and siCLIC1 cells). The voltage protocol is shown above the traces. By analytical subtraction 
of the ionic current after 100 µM IAA94 addition from the total current of the cell, we obtained 
the IAA94-sensitive current (IIAA94); the DIDS-sensitive current (IDIDS) is calculated by 
subtracting the current after 200 µM DIDS addition from the current after IAA94 effect. (B) 
shows I/V relationships for the corresponding experiments in A. Note that siCLIC cells 
display a complete abolishment of the CLIC1-mediated current, while the DIDS-sensitive 
current  is unaltered.   
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Figure 20.  siRNA abolishes CLIC1 currents in hGBMR1 CSCs.  (A) Rapresentative ionic 
current traces from perforated patches of CSCs from h70.01.42 tumors (not infected, siLuc 
and siCLIC1 cells). The voltage protocol is shown above the traces. By analytical subtraction 
of the ionic current after 100 µM IAA94 addition from the total current of the cell, we obtained 
the IAA94-sensitive current (IIAA94); the DIDS-sensitive current (IDIDS) is calculated by 
subtracting the current after 200 µM DIDS addition from the current after IAA94 effect. (B) 
shows I/V relationships for the corresponding experiments in A. As for 70.01.42 CSCs, 
siCLIC cells display a complete abolishment of the CLIC1-mediated current, while the DIDS-
sensitive current is unaltered.   
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Figure 21. CLIC1 Silencing Reduces the Protein Plasma Membrane Fraction in 
Glioblastoma CSCs.  These plots report the averages of the ratio of IAA94-sensitive currents 
(A, C) and DIDS-sensitive currents (B, D) over the total current of the same cell, for 
experiments performed in h70.01.42 (A, B) and hGBMR1 (C, D) glioblastomas CSCs.  
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Positive correlation between the relative abundance of CLIC1-
mediated current and glioblastoma aggressiveness 
In order to estimate how CLIC1-mediated current was represented compared to the other Cl- 
currents in h70.01.42 and hGBMR1 cells, we calculated the IIAA94/IDIDS ratio, defined as the 
relative abundance of CLIC1-mediated current. 
As shown in Figure 22, not infected and siLuc cells displayed a very similar IIAA94/IDIDS pattern at 
all membrane potentials explored, indicating that the lentiviral infection by itself did not affect ion 
channels function. On the other hand, in siCLIC1 cells the IIAA94/IDIDS ratio was close to zero in 
both tumors. For example at 0 mV, in not infected cells from h70.01.42 tumor we found that the 
IIAA94/IDIDS ratio was 0.65 + 0.16 (n = 9), in siLuc cells 0.52 + 0.15 (n = 10) and in siCLIC1 cells -
0.05 + 0.04 (n = 7) (Figure 22A). For hGBMR1 tumor, at 0 mV the IIAA94/IDIDS ratio was: not 
infected cells 1.10 + 0.41 (n = 5), siLUC cells 1.20 + 0.18 (n = 7) and siCLIC1 cells 0.07 + 0.03 
(n = 5) (Figure 22B). Interestingly, in not infected hGBMR1 cells the relative abundance of 
CLIC1-mediated current was about two fold bigger than in not infected h70.01.42 cells at 
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Figure 22. The relative abundance of CLIC1-mediated current compared to the other Cl- 
conductances in CSCs. (A, B) The ratio of IAA94-senstive current over DIDS-sensitive 
current is defined as the relative abundance of CLIC1-mediated current and is reported 
against membrane potential, for h70.01.42 (A) and hGBMR1 (B) glioblastomas CSCs.  
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membrane potentials comprised between -20 mV and +40 mV. Considering that the hGBMR1 
tumor is more aggressive than the h70.01.42 tumor, we asked whether the positive correlation 
between IIAA94/IDIDS ratio and tumor aggressiveness was a random coincidence or a real trend 
(where the aggressiveness is the time needed for CSCs inoculated in nude mice to generate a 
lethal tumor). 
 
To address this question, we included in our study other two human glioblastomas: h60.50.51 
and h60.90.12 (Figure 23). Perforated patch experiments on not infected CSCs revealed that 
also in these two tumors CLIC1-mediated current was constitutively present. For example at 20 
mV, the IAA94-sensitive current was 12.89% + 2.66% (n = 6) in the h60.90.12 cells and 22.09% 
+ 2.68% (n = 12) in the h60.50.51 cells. Thus, it appears that, in this last tumor, the average 
percentage of CLIC1-mediate current is more relevant than in the h60.90.12 CSCs.   
In Figure 24, it is shown a cumulative plot summarizing all the data collected from not infected 
CSCs in four different human glioblastomas. We found that the relative abundance of CLIC1- 
mediated current positively correlated with tumor aggresiveness, meaning that the longer the 
latency of tumor formation in nude mice the least aggressive the glioblastoma. For example, at 
0 mV membrane potential the ratio IIAA94/IDIDS was 0.5 + 0.12 (n = 6) in h60.90.12 cells, 1.18 + 
0.23 (n = 9) in h70.01.42 cells, 1.74+ 0.1 (n = 6) in hGBMR1 cells and 2.32 + 0.42 (n = 12) in 
h60.50.51 cells. In the tumors analyzed in this study, the average survival of nude mice 
inoculated with CSCs was: 152 ± 2 days for tumor h60.90.12, 128 ± 2 days for tumor h70.01.42, 
55 ± 4 days for tumor hGBMR1 and 88 + 4 days for tumor h60.50.51. Thus, in CSCs from the 
glioblastoma hGBMR1 CLIC1-mediated current is more represented than the other Cl- currents 
in the cells compared to the other tumors.  
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Figure 23. CLIC1 currents in h60.50.51 and h60.90.12 CSCs. (A, C) Rapresentative ionic 
current traces from perforated patches of CSCs from h60.50.51 (A) or h60.90.12 (C) 
tumors (not infected). The voltage protocol is shown above the traces. By analytical 
subtraction of the ionic current after 100 µM IAA94 addition from the total current of the 
cell, we obtained the IAA94-sensitive current (IIAA94); the DIDS-sensitive current (IDIDS) is 
calculated by subtracting the current after 200 µM DIDS addition from the current after 
IAA94 effect. (B, D) show I/V relationships for the corresponding experiments in A and C, 
respectively.  
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Figure 24.  Positive correlation between CLIC1 relative abundance and glioblastoma 
aggressiveness. This 3D plot correlates the relative abundance of CLIC1-mediated current 
(IIAA94/IDIDS), the membrane potential and the tumor aggressiveness (defined as the latency of 
tumor formation occurring after inoculation of CSCs in nude mice) for four different human 
glioblastomas. 
  
31 
 
 
Figure 25. Conventional therapies targeting glioblastoma tumor bulk cells (violet circles) lead 
to tumor regression, however, the presence of CSCs (green circles) in the residual tumor 
allows for tumor recurrence. To eradicate the tumor, new therapies should be targeted 
against CSCs (Dey et al., 2010).  
1.D DISCUSSION 
Glioblastoma remains one of the deadliest forms of cancer, in that infiltrating cancer cells in the 
surrounding brain prevents complete tumor removal upon surgery or radiation. Furthermore, the 
existence of cancer stem cells (CSCs) may explain the resistance of these tumors to 
conventional chemotherapies (Nduom et al., 2012). Indeed, CSCs are predicted to be difficult 
targets for therapeutics because (1) they cycle slowly, (2) express high levels of drug export 
proteins, and (3) they may not depend upon the oncoproteins targeted by the new generation of 
drugs. These observations would suggest that a new class of agents should be designed to 
specifically target CSCs (Figure 25) (Stiles and Rowitch, 2008). Thus, fundamental questions 
about the mechanisms of CSC tissue invasion need to be addressed. In fact, preventing tumor 
invasion would lead to more successful surgeries or radiation therapies. This thesis project 
explores the possibility that CLIC1 protein represents an important player in glioblastoma 
infiltration.  
 
CLIC1 appears to have a main role in diseases that involve oxidative stress, including tumors 
(Averaimo et al., 2010). Damage to living tissues is often initiated and propagated by oxidative 
stress. Since cancer is deeply related to inflammation and tissue repair (Mantovani, 2009), 
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Figure 26. Protrusion/retraction dynamics regulated by a redox mechanism.  Membrane 
protrusion at the leading edge of a migrating cell is promoted by a prevalence of oxidative 
events (red), with the opposite occurring at the retracting edge (purple) (Pani et al., 2010). 
CSCs are recruited and activated like in a healing wound: they migrate out of their niches and 
begin to make new tissue. Oxidative stress is not only the drive that recruits CSCs, but also 
what regulates their migration. For this task, the cytoplasmic local redox potential coordinates 
membrane protrusion at the cell front (Rac-dependent) and contraction at the trailing edge (Rho-
dependent) during cell migration (Figure 26) (Pani et al., 2010). CLIC1 appears to properly fit in 
this context, as it is a protein modulated by the oxidative status of the cell: upon oxidation, the 
cytoplasmic form of CLIC1 undergoes an extensive conformational change that leads to its 
translocation into the plasmamembrane (Averaimo et al., 2010; Singh, 2010). Here, acting as a 
Cl- channel, it may play a role in volume regulation and consequently migration. Moreover, 
CLIC1 is highly expressed in high grade gliomas (Wang et al., 2012). 
 
On this line of thoughts, we established primary cultures of CSCs from four different human 
glioblastomas biopsies. To investigate CLIC1 role, the cells are infected with lentiviruses 
engineered to bicistronically express siRNA against our protein and the Green Fluorescent 
Protein (GFP). GFP is used to assess transduction efficiency and to be able to recognize 
infected cells during electrophysiological experiments (where only green cells are studied). 
Western blot analysis reveals that CLIC1 protein is partially but efficiently silenced in siCLIC1 
cells from all the glioblastomas (50-80% protein reduction, depending on the tumor), but not in 
siLuc cells, suggesting that the viral infection per se is not affecting CLIC1 knock down (Figure 
17). The migration assay of CSCs shows that the efficiency of migration largely decreases (~50 
%) when CLIC1 is silenced (Figure 18). Being the intrinsic nature of CLIC1 the one of a 
dimorphic protein, it is legitimate to ask whether the migration impairment is mediated by the 
cytoplasmic protein fraction or by the transmembrane one. 
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Interestingly, electrophysiological recordings from siCLIC1 cells show that the IAA94-sensitive 
current (likely corresponding to the CLIC1-mediated current) is completely abolished, while in 
siLuc or not infected cells it ranges between 10-30% of the total current depending on the tumor 
analyzed. This is not an obvious result since CLIC1 silencing is partial in all the glioblastomas. 
Thus, the residual proteins could have been residing in the membrane and act as ion channel. 
Although the electrophysiology approach allows us to study only one cell at the time, it is 
important to note that the standard error of the mean for the percentage of CLIC1-mediated 
current in siCLIC1 cells is extremely small in all of the tumors analyzed (mostly inside the 
symbols, Figure 21 A&C), strengthening the results and pointing to little variability from cell to 
cell. On the other hand, DIDS-sensitive current shows more variability in amplitude, but not a 
significant difference between siCLIC1 and siLuc cells from the same tumor (Figure 21 B&D). 
This is not surprising being DIDS an aspecific Cl- channel inhibitor.  
Taken together, these data strongly support the view that the CSCs migration impairment 
measured with the Boyden chamber assay is due to the lack of a functional CLIC1 protein as an 
ion channel. This action could be mediated through several mechanisms: 
- by allowing Cl- ions out of the cell, CLIC1 may participate in the volume rearrangements 
needed for a cell to change shape and infiltrate in narrow interstitial spaces; 
- since it has been shown that CLIC1 interacts with the F-actin (Singh et al., 2007), it may 
participate in the reorganization of the cytoskeleton that leads to invadopodia formations;  
- CLIC1 may act by supporting the function of the NADPH-oxidase (shown to be active during 
tumor cell migration (Pani et al., 2010) and balancing the superoxide negative charges 
produced by this enzyme (Averaimo et al., 2010; Milton et al., 2008). 
If CLIC1 plays such a key role, it is important to quantify the relative abundance of CLIC1-
mediated currents compared to the other Cl- conductances in human glioblastomas CSCs that 
are not infected with lentiviruses. We find that the bigger is the relative abundance of CLIC1-
mediated current, the more aggressive is the glioblastoma (Figure 24). However, western blot 
data show that the total protein (from all cellular compartments) does not correlate with tumor 
aggressiveness. Thus, the plasmamembrane fraction of CLIC1, and not the cytoplasmic one, 
appears to confer a worst outcome to the tumor. These findings suggest CLIC1 as a possible 
pharmacological target to contrast the invasiveness of glioblastoma. Being the transmembrane, 
and more accessible, fraction of this protein involved, it will be relatively easier to design a drug 
against CLIC1. Also, the other functions carried out by the cytoplasmic portion of this protein will 
be likely unaffected. Further experiments are needed to discriminate among the possible 
mechanisms that involve CLIC1 in glioblastoma infiltration to possibly find other 
pharmacological targets. 
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CHAPTER 2:  Ca2+ and voltage dependent 
structural changes in the human BK channel 
during operation revealed by voltage clamp 
fluorometry 
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2.A INTRODUCTION 
Allostery 
Allostery is an intrinsic property of all proteins, which allows distant sites to be energetically 
coupled, resulting in a common and efficient regulation of many biological processes. Allostery 
can originate from binding events, covalent modifications, mutations or changes in the 
environment (Goodey and Benkovic, 2008; del et al., 2009; Morange, 2012). The word 
‘allosteric’ was introduced by Jacques Monod to explain how an inhibitor binding to another site 
induced a conformational change of the protein that modified the active site (MONOD and 
JACOB, 1961). The long-range interactions between amino acids in different parts of a protein 
are remarkable, and the effects of binding, covalent modification or mutation can be felt through 
great distances. Proteins exist in a dynamic equilibrium of preexisting conformations and their 
ligands shift the distribution of conformers by increasing entropy via amino acid side-chain 
dynamics (Tsai et al., 2008).  
According to this wide definition, also ion channels are modulated by allosteric processes. 
Indeed, their gating mechanism(s) relies on the allosteric coupling between the pore and other 
modulatory domains, specialized to sense different stimuli, such as changes in membrane 
potential, temperature, mechanical stress and concentration of signaling molecules. In 
particular, the large-conductance Ca2+- and voltage-gated K+ (BK) channel is an excellent 
example of allosteric protein. 
 
The BK Channel 
BK channels allosterically open in response to membrane depolarization and binding of different 
ligands, such as Ca2+, Mg2+, Heme, H2O2, lipids (Latorre et al., 2010; Cui et al., 2009; Lee and 
Cui, 2010; Hou et al., 2009). Physiological and pathophysiological roles played by BK channels 
are diverse. For example, in some neurons, activation of BK channels contributes to fast after-
hyperpolarization (Muller et al., 2007), regulating action potential firing frequency (Gu et al., 
2007) and neurotransmitter release (Figure 27) (Hu et al., 2001; Lancaster et al., 2001). In 
smooth muscle cells, opening of BK channels promotes muscle relaxation (Nelson and Quayle, 
1995). Furthermore, in endocrine and exocrine cells, BK channels control hormone release 
(Petersen and Maruyama, 1984). Other physiological phenomena involving BK channels include 
skeletal muscle fatigue (Tricarico et al., 2005), regulation of circadian rhythm (Meredith et al., 
2006), ethanol tolerance (Cowmeadow et al., 2006), and nociception (Hendrich et al., 2012). As 
expected from these diverse roles, a variety of pathological consequences may arise from BK 
channel impairment, including erectile dysfunction (Werner et al., 2005), incontinence, 
hypertension (Grimm and Sansom, 2010), asthma (Seibold et al., 2008), epilepsy and 
dyskinesia (Du et al., 2005).  
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Figure 27. A model for the functional role of BK channels in the neurotransmitter release. (A) 
Schematic representation of a neuromuscular junction: when the axon depolarizes upon 
action potential arrival, voltage gated Ca2+ (CaV) channels open and intracellular [Ca2+] 
increases, allowing acetylcholine (Ach)-containing vesicles to fuse with the membrane. Ach 
binds to Ach ionotropic receptors that let Na+ into the myocyte, inducing a depolarization that 
triggers an action potential and myocyte contraction. (B) Ca2+ in the pre-sinaptic terminus 
also activates BK channels, accelerating repolarization: CaV channels close and Ach release 
stops. A similar mechanism, involving a tight coupling between BK and CaV channels, also 
exists in smooth muscle cells and in hormone-secreting cells. 
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BK channel different functions are made possible by their structural and functional diversity 
conferred by multiple mechanisms. For example, while only one gene encodes for the pore-
forming subunit (KCNMA1, Slo1), its transcript is extensively spliced (Fodor and Aldrich, 2004; 
Adelman et al., 1992). Also, co-assembly with auxiliary subunits β1, β2, β3, β4, and leucine-rich 
repeat-containing proteins (LRRCs; γ subunits) increases functional diversity by modulating 
Ca2+ and voltage sensitivity as well as their kinetic properties (Wallner et al., 1995; Yan and 
Aldrich, 2012; Jiang et al., 1999). Participation in formation of macromolecular complexes with 
other proteins and posttranslational modifications further expand the BK channel functions (Lu 
et al., 2006; Berkefeld et al., 2010).   
One functional BK channel is composed of four identical subunits (Shen et al., 1994), each 
containing ~1,100 residues (Figure 28). In addition to transmembrane helices S1-S6, which are 
found in voltage-dependent K+ (KV) channels, a seventh transmembrane segment (S0) exists in 
BK, such that its N terminus faces the extracellular side (Figure 28) (Meera et al., 1997; Wallner 
et al., 1996). An atomic structure of the transmembrane domain of the BK channel is not yet 
available.  However, homology models have been constructed using the atomic structure of the 
Kv1.2/2.1 chimeric channel (Long et al., 2007) as the template (Figure 29). The location of S0 
has been inferred from functional studies utilizing disulfide crosslinking of engineered cysteine 
residues (Liu et al., 2010) and collisional fluorescence quenching (Pantazis and Olcese, 2012), 
placing S0 close to S3 and S4. Transmembrane segments S0--S4 represent the voltage sensor 
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Figure 28. Membrane topology of BK α and β subunits. Transmembrane helices S1-S6 are 
homologous to those of other KV channels, but S0 is unique in BK channels. Helices S2-S4 
bear charged, voltage-sensing residues, indicated according to their valence. The BK 
intracellular C-terminus encompasses the RCK1 and RCK2 regulatory domains (each with 
one high-affinity Ca2+ sensor) and the heme-binding motif. Auxiliary β subunits consist of two 
transmembrane domains (TM1 and TM2) and a large extracellular loop. 
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domain (VSD) of each subunit (four VSD per channel), in that they are rich in charged amino 
acids. Helices S5 and S6 from all four subunits form the pore domain. 
 
The transmembrane region of BK channel includes about a third of the total amino-acid 
residues, and the remainder forms the cytoplasmic C-terminal domain, which is structurally 
organized into two tandem RCK (regulator of conductance for K+) domains (RCK1 and RCK2).  
Despite their modest primary sequence similarity, RCK1 and RCK2 exhibit a three-dimensional 
structural similarity (Figure 29) (Yuan et al., 2010; Yuan et al., 2011; Wu et al., 2010). Each 
RCK domain possesses a micromolar-affinity Ca2+ sensing region: the RCK1 Ca2+ sensor (Xia 
et al., 2002; Yusifov et al., 2010) and the RCK2 Ca2+ sensor (Yusifov et al., 2008), referred to as 
the “Ca bowl” (Schreiber and Salkoff, 1997).  A short stretch of about 20 residues connects the 
transmembrane helix S6 and RCK1 (S6-RCK1 linker), while ~100 residues link RCK1 and 
RCK2. 
In the tetrameric BK channel, four pairs of RCK1-RCK2 domains assemble to form a large 
cytoplasmic structure called the “gating ring” (Figure 29) (Wu et al., 2010; Yuan et al., 2010; 
Yuan et al., 2011). The transmembrane and gating ring domains are proximal enough for close 
reciprocal functional interactions (Yang et al., 2008). The exact distance and radial alignment 
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Figure 29. BK channel putative structure. (A) Side view of a putative structural model of the 
BK channel, composed of the BK gating ring structure (PDB# 3NAF, white), manually 
associated with the transmembrane portion of the KV1.2-2.1 paddle chimera (PDB #2R9R), 
and S0 ideal helices positioned according to Liu and coworkers (Liu et al., 2010; Long et al., 
2007; Wu et al., 2010). The pore domain is shown in gray, while VSD helices are shown in 
orange, except S4 (purple). (B) Top view of the gating ring structure overlaid by the 
“footprint” of the KV1.2-2.1 transmembrane domains. The high affinity Ca2+ binding site in 
RCK2 (Ca bowl) is highlighted in red, while two of the putative Ca2+-coordinating residues in 
RCK1 are in red. 
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Gating Ring
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D362, D367 (RCK1)
S4
A Top viewSide view B
between the transmembrane and cytoplasmic domains remains unknown. The outer diameter of 
the gating ring is ~15 nm and the diameter of the central star-shaped hole in the gating ring is 
~4 nm.  
 
The recent crystal structures of BK gating ring have shown that both the RCK1 and RCK2 Ca2+ 
sensing sites are located close to the transmembrane region of the channel (Figure 29) (Wu et 
al., 2010; Yuan et al., 2010; Yuan et al., 2011). Furthermore, BK channels have been recently 
found to be modulated by the prosthetic group heme through the heme-binding motif CKACH in 
the RCK1-RCK2 linker (Figure 28) (Horrigan et al., 2005; Tang et al., 2003).  
 
The voltage sensor domain 
In cells, a lipid bilayer membrane separates the cytoplasm from the external medium. The 
concentration of different ionic species equilibrates across the bilayer according to their 
electrochemical gradient (Bezanilla, 2008; Swartz, 2008). This generates a charge separation 
across the membrane, which translates into a membrane potential that is ranging between ~-
40mV and ~–100 mV (negative inside the cell) depending on the cell type and the cell cycle 
phase. An electric charge or an electric dipole can be re-orientated within a transmembrane 
protein when the electric field across the membrane changes, eventually producing a protein 
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Figure 30. Possible mechanisms of voltage sensing. The schematic drawing of a 
transmembrane protein (orange oval) and different voltage-sensing active sites are shown. 
(a) Charged amino acids (Asp and Arg) move within the membrane in response to 
membrane potential changes. (b) Reorientation of an intrinsic residue dipole, such as Tyr, 
through changes in the electric field. (c) A membrane-spanning α-helix possesses a dipole 
moment (red to blue gradient) equivalent to the length of the helix that separates ±0.5 
electronic charges (e0); the oval attached to the α-helix represents a fluorophore that 
changes emission according to the protein conformation. (d) A channel within the protein can 
redistribute ions (light blue circle) according to the direction of the electric field and initiates a 
conformational change (Bezanilla, 2008).  
structural change that may regulate its function (Bezanilla, 2008). The movement of the charge 
or the dipole induces a transient current (gating current) that can be measured (Armstrong and 
Bezanilla, 1973). In proteins, the electric field is sensed through different mechanisms (Figure 
30). Charged amino acids such as Asp, Glu, Arg, Lys and His are likely candidates since they 
can orientate in the field (Figure 30a). Alternatively, amino acid side chains with an intrinsic 
dipole moment such as Tyr (Figure 30b) may sense the voltage. Although not yet identified as a 
voltage sensor, the α-helix with its intrinsic dipole moment represents a potential 
voltage-sensing structure (Figure 30c). Proteins also contain cavities where free ions can 
associate; changes in an electric field might move the free ion, likely resulting in a 
conformational change of the protein (Figure 30d) (Bezanilla, 2008). 
 
A notable example of voltage-sensing domain (VSD) is the S1–S4 transmembrane segments of 
voltage-activated ion channels.  When these channels were first cloned, the fourth putative 
membrane-spanning segment, S4, stood out because of its several positively charged residues 
(Arg or Lys ) (Noda et al., 1986; Tempel et al., 1987). S1–S3 segments also contain charged 
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Figure 31. Scheme of S1–S4 VSDs in different types of membrane proteins. In voltage-
activated ion channels, the S1–S4 domains (VSD) couple to an ion-selective pore domain 
(yellow); only one of four VSD is shown for clarity. In enzymes such as the Ci-VSP, VSD 
couples to a phosphatase domain (yellow), while in voltage-activated proton channels, 
protons are thought to directly permeate the VSD (Swartz, 2008). 
Charge‐
carrying 
segments
residues, and the four segments collectively form the VSD. Although S1–S4 voltage-sensing 
domains were originally thought only to exist in voltage-activated ion channels, it has been 
recently shown that a VSD exists in a phosphatase from the Ciona intestinalis to regulate the 
hydrolysis of membrane phosphoinositides (Figure 31) (Murata et al., 2005; Kohout et al., 
2008). Another S1–S4 domain protein without a separate pore domain was shown to function as 
a voltage-activated proton channel (Figure 31) (Sasaki et al., 2006; Ramsey et al., 2006).  
 
The X-ray structures of the bacterial KVAP and the eukaryotic Kv1.2 channel provided 
information about the tridimensional distribution of S1–S4 domains with respect to the pore: the 
VSD adopts transmembrane orientation and appears loosely attached to the pore domain (Jiang 
et al., 2003b; Long et al., 2005; Long et al., 2007). 
In the BK channel, conserved transmembrane helices S1-S4 constitute the VSD together with 
the S0 segment. In fact, in addition to the role of S0 in mediating functional assembly of BK 
channel α and β subunits (Meera et al., 1997; Wallner et al., 1996), S0 can contribute to the 
VSD function (Koval et al., 2007; Pantazis et al., 2010b). Electrophysiological studies estimate 
that the four VSD carry overall 2.4 charges per channel (Horrigan and Aldrich, 1999; Horrigan et 
al., 1999; Diaz et al., 1998), remarkably less than a typical Kv channel (up to ~16 charges per 
channel (Jensen et al., 2012). In fact, the S4 segment of the BK channel typically contains four 
positively-charged Arg residues (R0, R2, R3, and R4 equivalent to Kv channels) (Figure 32); 
however only R4 plays a role in voltage sensing (Ma et al., 2006). A further difference of BK 
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Figure 32. S2-S4 transmembrane segments of BK and KV channels. The multiple sequence 
alignment of VSD from mouse and Drosophila (mSlo1, dSlo1) BK channels and KV channels 
(KV2.1, KVAP, Shaker, KV1.2) is shown (Ma et al., 2006). Transmembrane segments are 
denoted by solid lines based on hydropathy analysis of BK (Wallner et al., 1996) and dashed 
lines based on the crystal structure of KVAP (Jiang et al., 2003a). Highly conserved charged 
residues are in bold. Voltage-sensing residues in Shaker are indicated by stars. 
VSD from a typical Kv channel resides in the fact that charged amino acids in S2 and S3 
contribute significantly to voltage sensing (Ma et al., 2006); thus the voltage-sensing charges in 
the BK channel are fewer and more “decentralized” than in Kv channels (Figure 32). 
Specifically, S2 harbors two voltage-sensing residues, Asp135 and Arg167, and an additional 
voltage-sensing charge is located in S3 (Asp186) (Ma et al., 2006). This arrangement may allow 
BK channel to respond in a finely graded manner under diverse conditions. This charge 
distribution results in complex relative motions occurring during voltage-dependent activation: 
fluorometry experiments suggest that, upon depolarization, S4 diverges from S0, S1 and S2, 
while S2 approaches S1 (Pantazis and Olcese, 2012; Pantazis et al., 2010b).  
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Moreover, S2 and S4 segments reciprocally enhance their voltage-sensing properties in a 
cooperative fashion (Pantazis et al., 2010a). Consistent with the idea that multiple voltage-
sensing charges at different loci are involved in the voltage-sensing process, BK gating currents 
may show multiple kinetic components (Contreras et al., 2012). In Kv channels, the S4-S5 linker 
appears to work as a linkage mechanism connecting the VSD movement to opening of the ion 
conduction gate at the cytoplasmic ends of the four S6 segments (Jensen et al., 2012; Long et 
al., 2007). In the BK channel, the structural correlates of the VSD-gate coupling mechanism 
have not been clearly revealed yet. The S6-RCK1 linker, connecting the transmembrane region 
of the protein with the gating ring domain, may contribute to the VSD-gate coupling process. 
Shortening or lengthening of this linker segment in the absence of Ca2+ alter the the Po-V curve 
position on the voltage axis without a major change in their curve steepness (Niu et al., 2004). 
Furthermore, a Leu residue and a Phe residue located in the middle of S6 have been suggested 
to mediate the influences of VSD activation and Ca2+ binding on the ion conduction gate 
equilibrium (Wu et al., 2009).   
 
Ca2+ sensors and the gating ring  
Under physiological conditions, BK channels are activated by Ca2+ binding to the Ca2+-sensing 
sites in RCK1 and RCK2, the constituents of the gating ring structure.  Changes in [Ca2+]i, in the 
range of 100 nM to 300 µM, alter different aspects of BK channel gating. For example, single-
channel Po increases; the mean closed duration decreases, while the mean open duration 
increases (Rothberg and Magleby, 1999). Moreover, the half-activation potential (Vhalf) of 
macroscopic ionic currents shifts from >150 mV to ~0 mV when the Ca2+ sensors are fully 
activated by 300 µM of Ca2+ (Horrigan and Aldrich, 2002; Sweet and Cox, 2008). Greater 
concentrations of Ca2+ as well as of other divalent cations ions such as Mg2+ (>1 mM) produce 
additional activation (Zeng et al., 2005). This “low-affinity” response is often referred to as Mg2+-
dependent activation because the underlying mechanism has been studied primarily with Mg2+ 
(Shi and Cui, 2001; Shi et al., 2002). The “low-affinity” (Mg2+-dependent) activation and the 
“high-affinity” (Ca2+-dependent) activation processes are electrophysiologically different, 
reflecting their distinct molecular mechanisms (Horrigan and Ma, 2008; Yang et al., 2007). Thus, 
the BK gating ring operates as a chemomechanical transducer, converting the free energy of 
divalent cation binding into structural rearrangements. These structural transitions constitute the 
molecular basis by which this second messengers ultimately favor gate opening and VSD 
activation.  
The RCK2 high-affinity Ca2+ sensor was identified soon after the BK channel gene was cloned 
(Adelman et al., 1992): it comprises five consecutive negatively charged Asp residues and it is 
named Ca bowl (Schreiber and Salkoff, 1997). The recent crystal structure of BK gating ring 
shows that the Ca bowl is located in a loop segment (~16-20 residues) of the RCK2 domain 
(Figure 33) (Yuan et al., 2010; Yuan et al., 2011). The oxygen atoms that coordinate Ca2+ are 
provided by the backbone carbonyl groups of Gln889 and Asp 892, and by the side chains of 
Asp895 and Asp897. In the absence of bound Ca2+, the Ca2+-coordinating oxygen atoms are 
more dispersed in space, presumably because their electronegative oxygen atoms repel each  
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Figure 33. Gating ring structure. (A) Top view of the tetrameric gating ring structure using 6.0 
Å diffraction data. RCK1 is shown in blue, RCK2 in red and Ca2+ ions as yellow spheres. (B) 
Structure of the Ca bowl, showing key residues coordinating the Ca2+ ion (Yuan et al., 2010).  
A B
 
other (Wu et al., 2010). These structural changes induced by Ca2+ coordination in the Ca bowl 
likely lead to experimentally detectable changes in the whole gating ring assembly, culminating 
in the stabilization of the open conformation of the ion conduction gate. The apparent Ca2+ 
dissociation constant (Kd) of the RCK2 Ca2+ sensor has been electrophysiologically estimated 
to be ~3 and ~0.9 µM, depending on whether the ion conduction gate is closed or open, 
respectively (Sweet and Cox, 2008). The neutralization of Ca2+-coordinating residues within the 
Ca bowl partially impairs the negative shift of the Po(V) curve by Ca2+ and binding of Ca2+ to C-
terminal protein fragments (Bao et al., 2004; Bian et al., 2001; Schreiber and Salkoff, 1997), 
suggesting that the Ca bowl is indeed a Ca2+ sensor. However, the mutations do not fully 
abolish the BK Ca2+ sensitivity in either electrophysiological (Schreiber and Salkoff, 1997) or 
biochemical assays (Bao et al., 2004; Bian et al., 2001; Javaherian et al., 2011), hinting the 
existence of a second Ca2+ sensor. However, the atomic structures of the isolated gating ring 
domain (PDB IDs 3MT5 and 3U6N) solved in the presence of mM levels of Ca2+ (Yuan et al., 
2010; Yuan et al., 2011) do not show any Ca2+ bound other than to the Ca bowl. To date, the 
consensus is that at least three amino-acid residues, non-contiguous in the primary sequence, 
participate in Ca2+ coordination in RCK1: Asp367 side chain (Xia et al., 2002), the Glu535 side 
chain and Arg514 backbone (Zhang et al., 2010). In addition, Met513 may participate in 
formation of the RCK1 sensor (Bao et al., 2002). The apparent Ca2+ dissociation constants of 
the RCK1 sensor are electrophysiologically estimated to be ~23 and 4.9 µM when the ion 
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conduction gate is closed and open, respectively (Sweet and Cox, 2008); thus, greater 
concentrations of Ca2+ are required to activate the RCK1 sensor than the RCK2 sensor.  
As already mentioned above, the BK gating ring is a tetramer of RCK1-RCK2 tandems. Its 
atomic structures obtained with or without Ca2+ reveal that the gating ring assumes different 
conformations (Yuan et al., 2010; Yuan et al., 2011; Wu et al., 2010). In particular, it appears 
that Ca2+ binding to the RCK2 sensors rearranges the gating ring so that the layer of the gating 
ring domain immediately juxtapositional to the transmembrane segments opens up (Yuan 
2011). Presumably, it is the free energy change associated with these conformational changes 
in the cytoplasmic gating ring domain that ultimately promotes opening of the ion conduction 
gate. Spectroscopic studies of the isolated tetrameric gating ring domain in solution show that 
Ca2+ binding reversibly causes the gating ring domain to assume a more hydrodynamic shape 
(Javaherian et al., 2011).   
 
An allosteric model for BK channels 
In BK channels, the VSD or the Ca2+ sensors ability to influence a concerted conformational 
change (pore opening) in a nonobligatory fashion is well described as allosteric mechanisms 
(MONOD et al., 1965). A dual allosteric model (Figure 34) has been implemented to account for 
the features of BK channel activation and provides a useful framework for analyzing BK channel 
gating in terms of domain/domain interactions (Horrigan and Aldrich, 1999; Horrigan et al., 
1999; Horrigan and Aldrich, 2002; Horrigan, 2012). The HA (Horrigan-Aldrich) model asserts 
that the pore can undergo a closed to open (C-O) transition, regulated by four independent and 
identical voltage- and Ca2+-sensors. VSDs can be in a resting (R) or activated (A) conformation, 
whereas Ca2+ sensors can be Ca2+ free (X) or Ca2+ bound (X-Ca2+) (Figure 34). The function of 
each domain is defined by equilibrium constants for gate opening (L), voltage-sensor activation 
(J), and Ca2+ binding (K). The degree of cooperativity between domains is represented by 
allosteric factors (C, D, and E), which define the ability of a transition in one domain to affect the 
equilibrium constant in another (Horrigan and Aldrich, 2002).  
In the absence of Ca2+ and when the ion conduction gate is closed, the VSD of the BK channel 
is more stable in the resting conformation. Large depolarizations are required to fully drive the 
VSD to the activated conformation. However, binding of Ca2+ to the BK channel dramatically 
biases the VSD equilibrium towards the activated conformation both indirectly through the 
sequential coupling of the Ca2+ sensor to the ion conduction gate (allosteric factor “C” in the HA 
model) and to the VSD (allosteric factor “D”) and directly through the coupling between the Ca2+ 
sensor and the VSD (allosteric factor “E”) (Horrigan and Aldrich, 2002). Thus, Ca2+-binding 
promotes BK channel activation at more physiological potentials. Similarly, binding of Ca2+ to 
the Ca2+ sensors of the channel increases the probability the ion conduction gate is open, and 
opening of the gate in turn increases the affinity of the sensors to Ca2+.  Finally, VSD activation 
also increases the Ca2+ affinity, and Ca2+ binding, in turn, promoting VSD activation. 
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Figure 34. Horrigan and Aldrich (HA) allosteric model for BK activation. The cartoon 
represents one BK channel subunit whose pore can undergo a transition from the closed to 
the open configuration, according to the equilibrium constant L. Depolarizations activate 
VSDs facilitating pore opening by the allosteric factor D. Ca2+ binding also facilitates the 
channel opening (allosteric factor C) (Latorre et al., 2010). In the inset, the HA allosteric 
model scheme is reported (Horrigan and Aldrich, 2002).  
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2.B METHODS 
Molecular biology  
Mutagenesis: Single point mutations were generated with the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene, CA). In vitro site-directed mutagenesis is a very useful tool to 
study the relationship between protein structure and function. The QuikChange site-directed 
mutagenesis method allows site specific mutation in double-stranded plasmids. It is performed 
using PfuUltra™ high-fidelity DNA polymerase. The PCR product is controlled on a 1% agarose 
gel and then transformed into competent bacteria, XL1-blue, using the appropriate selective 
antibiotics.  The mutations were then confirmed by sequencing. 
A hSlo clone (#U11058) without extracellular Cysteines (C14S-C141S-C277S) was used. 
Background mutations also included R207Q and W203V to increase PO (Diaz et al., 1998; Ma et 
al., 2006) and fluorescence signal (Savalli et al., 2006), respectively. A single Cysteine was 
substituted in position 202 in the short S3-S4 linker (S202C) for site directed fluorescence 
labeling (Pantazis et al., 2010a; Savalli et al., 2006; Savalli et al., 2007). Throughout the thesis, 
this clone is referred-to as pseudo-WT (pWT). The two high-affinity Ca2+ sensors were 
separately neutralized generating the D362A/D367A (in RCK1) and the D894-898N (in RCK2 / 
Ca bowl) mutants. We also used the non-inactivating Shaker K+ channel (Sh-IR, #M17211). For 
site-directed fluorescent labeling, we introduced a unique cysteine in the S3-S4 linker, 
generating the Sh-IR-M356C channel (Cha and Bezanilla, 1997; Mannuzzu et al., 1996).  
In vitro transcription: The plasmids carrying cDNAs of pWT and mutant channels were linearized 
with a specific single-cutter restriction enzyme (generally Not I, New England Bioloab). The 
linear cDNA was then used as the template for the in vitro transcription (1-2 μg per reaction) to 
produce capped cRNAs (mMESSAGE MACHINE; Ambion, Austin, TX). Capped RNA mimics 
most eukaryotic mRNAs found in vivo, because of a 7-methyl guanosine cap structure at the 5' 
end. The reaction of the in vitro transcription kit includes the cap analog [m7G(5')ppp(5')G], 
which is incorporated as the first or 5' terminal G of the transcript because its structure 
precludes its incorporation at any other position in the RNA molecule. The reaction ran at 37oC 
for 2h. The cRNA was then precipited with LiCl2 at 20oC and resuspended in water. After 
assessing RNA concentration with the spectrophotometer (λ= 260 nm) and RNA quality by 
agarose gel, cRNA was stored at –80oC. 
 
Oocyte preparation and injection 
Xenopus laevis (NASCO, Modesto, CA) oocytes are an excellent system where to express ion 
channels for electrophysiological studies, as their large size (~1 mm diameter) allows the micro-
injection of cloned RNA into their cytosol, which they readily translates into functional proteins. 
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Figure 35. Mature Xenopus oocytes after 
defolliculation. 
After surgical excision from the frog, the oocytes 
(stage V-VI) were defolliculated via a mechanical 
and enzymatic treatment (collagenase type I in a 
Ca2+-free solution) (Figure 35). The same day of 
preparation or the day after, oocytes were 
injected with 50 nl of total cRNA (0.01-0.1 μg/μl) 
using a Drummond nano-injector. Injected 
oocytes were maintained at 18oC in an 
amphibian saline solution supplemented with 50 
μg/ml gentamycin (Invitrogen, Carlsbad, CA), 
200 μM DTT (to prevent that the external 
cysteines engage in disulfide bonds) and 10 μM 
EDTA. Three to six days after injection, oocytes 
were stained for 30 min with 10 μM membrane-impermeable, thiol-reactive fluorophore, tetra-
methyl-rhodamine-5’-maleimide (TMRM) (Molecular Probes, Eugene, OR) in a depolarizing K+ 
solution (in mM: 120 K-Methanesulfonate (MES), 2 Ca(MES)2, and 10 HEPES, pH=7). TMRM 
stock (100 mM) was dissolved in DMSO and stored at -20oC. The oocytes were then thoroughly 
rinsed in a dye-free solution and loaded with the caged compound DM-Nitrophen (100 nl at 2.5 
mM) prior to being mounted in the recording chamber. 
 
Voltage clamp fluorometry  
Voltage clamp fluorometry is a powerful technique to optically track protein conformational 
rearrangements. It takes advantage of the fact that many fluorophores are sensitive to their local 
environment (Lakowicz, 2006). It is possible to conjugate such fluorophores to a specific protein 
site and, if this area undergoes a motion that results in a change of the fluorophore 
environment, a deflection in the fluorescence emission will be observed. Voltage clamp 
fluorometry was pioneered in Shaker K+ channels expressed in oocytes clamped by two-
electrode voltage clamp (Mannuzzu et al., 1996), and was shortly after implemented in the Cut-
open Oocyte Vaseline Gap (COVG) voltage clamp technique (Cha and Bezanilla, 1997).  
The COVG technique (Stefani and Bezanilla, 1998) is a low-noise, fast clamp technique that 
can allow control of the internal solution. The oocyte is mounted in a triple-compartment 
Perspex chamber, with a diameter of 600 µm for the top and bottom holes (Figure 36). The 
voltage clamp circuit is then assembled around the mounted oocyte by the placement of six salt 
bridges and one intracellular electrode, imposing three simultaneous voltage clamps. The three 
chambers are electrically-isolated by Vaseline gaps: the upper chamber isolates the oocyte 
upper domus and maintains it under clamp; the middle chamber provides a guard shield by 
clamping the middle part of the oocyte to the same potential as the upper chamber; the bottom 
chamber allows to clamp to ground the intracellular compartment of the oocyte, through the 
saponin-permeabilized membrane. Changes in fluorescence signal and ionic currents were 
simultaneously measured from the same area of membrane isolated by the top chamber 
(Gandhi and Olcese, 2008). The optical setup consists of a Zeiss Axioscope FS microscope 
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Figure 36. Voltage-clamp fluorometry. It is shown a schematic drawing of the COVG 
recording chambers, the fluorescence light path, the photodetector circuit, and the COVG 
circuit. The bottom chamber (filled with internal solution) is held at ground, and the middle 
chamber and upper chambers (filled with external solution) are clamped to the command 
membrane potential. Fluorescence emission and ionic current are recorded from the oocyte 
membrane isolated in the upper chamber. The fluorescence is detected by a photodiode 
connected to a low noise current amplifier (Gandhi and Olcese, 2008). 
with filters appropriate for TMRM (Omega Optical, Brattleboro, VT). The light source is a 100 W 
microscope halogen lamp. A TTL-triggered Uniblitz VS 25 shutter (Vincent Associates, 
Rochester, NY) is mounted on the excitation light path. The Objective (Olympus LUMPlanFl, 
40×, water immersion) has a numerical aperture of 0.8 and a working distance of 3.3 mm 
(Olympus Optical). The emission light is focused on a PIN-08-GL photodiode (UDT 
Technologies, Torrance, CA). A Dagan Photomax 200 amplifier is used for the amplification of 
the photocurrent and background fluorescence subtraction. For the UV flash photolysis of caged 
Ca2+, the Xe flash lamp system JML-C2 was used (Rapp Opto-electronik GmbH, Hamburg, 
Germany), which delivers high-energy UV flashes of adjustable intensity. An external trigger is 
used to synchronize flashes with voltage clamp and optical recordings.  
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A quartz water immersed light guide was positioned ~0.5 mm away from the oocyte. The 
external solution contained (mM): 60 Na-MES, 50 K-MES, 2 Ca-(MES)2, 10 Na-HEPES 
(pH=7.0). The internal solution contained (mM): 120 K-Glutamate, 10 HEPES (pH=7.0). Solution 
for the intracellular micro-pipette was (mM): 2700 Na-MES, 10 NaCl. Low-access resistance to 
the oocyte interior was obtained by permeabilizing the oocyte with 0.1% saponin dissolved in 
the internal solution.  
Analysis: Experimental data were analyzed with a customized program developed in our 
Division and using fitting routines running in Microsoft Excel. The G(V) curves were calculated 
dividing the current-voltage relationships (I-V curves) by the driving force (Vm- EK), where Vm is 
the membrane potential and EK the equilibrium potential for K+, estimated using the Nernst 
equation. Data for the membrane conductance (G(V)) and the fluorescence (F(V)) curves were 
fitted to one Boltzmann distributions of the form:   
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where Gmax and Fmax are the maximal G and F; Fmin is the minimal F; z is the effective valence of 
the distribution; Vhalf is the half-activating potential; Vm is the membrane potential; F, R and T are 
the usual thermodynamic values. For each experiment, G(V) and F(V) curves were constructed 
before and after UV flash-induced Ca2+ release.  
Statistical Analysis: Scatter plots of ΔVhalf vs. ΔkTln[Ca2+]i were tested for monotonicity using 
Spearman’s rank order correlation coefficient (ρ) using the statistical software SigmaStat (Aspire 
Software, Ashburn, VA). ΔVhalf data were normalized to unitless quantities by multiplying by the 
fitted values for charge displacement (zL for ΔGVhalf and 4zJ for ΔFVhalf) and dividing by the 
change in chemical potential for calcium Δμ = ΔkTln[Ca2+]i. The collective mean of these 
normalized quantities, which can be interpreted as a measure of thermodynamic linkage 
between Ca2+- and voltage–sensing elements of the channel, was assessed for nonzero value 
using Student’s t-test.  
 
Caged Ca2+ compounds 
The term “caged compounds” was first used in 1978 by physiologists to refer to the functional 
encapsulation of ATP by use of a photochemical protecting group. Chromophore excitation 
leads to photolysis of a covalent bond, liberating the caged chemical messenger (Ellis-Davies, 
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Figure 37. DM-nitrophen is a photo-sensitive Ca2+ chelator. DM-nitrophen is an EDTA 
molecule (green) attached to a 2-nitophenyl group (blue). When the 2-nitophenyl group 
absorbs a UV photon, the EDTA group breaks into two molecules with lower affinity for Ca2+, 
effectively releasing Ca2+  (Faas and Mody, 2012). 
2007). Among other molecules, Ca2+ is efficiently released by photochemical lysis of the 
chelator backbone, converting a high affinity, tetracarboxylic acid chelator into two low affinity 
dicarboxylic acid molecules. 
In this thesis, to induce a fast increase of [Ca2+] in the oocytes, a caged Ca2+ compound was 
used: DM-nitrophen (1-(4,5-dimethoxy-2-nitrophenyl)-1,2-diaminoethane-N,N,N′,N′-tetraacetic 
acid).  DM-nitrophen is an EDTA moiety, which strongly binds Ca2+ (Kd ~5 nM), fused with a 2-
nitophenyl group that makes the molecule light sensitive (Figure 37). When a UV photon hits 
DM-nitrophen, it breaks a covalent bond in the EDTA backbone, rapidly producing two products 
with much lower affinity for Ca2+ (~3 mM) and thus releasing Ca2+ (Faas and Mody, 2012) . 
 
Patch clamp 
To construct a calibration curve for BK channel activation at different [Ca2+]i, the patch clamp 
technique was used (see Methods in the first chapter for a brief historical mention on the patch 
clamp).  
BK channels were overexpressed in Xenopus oocytes. 1-2 days after injection, the vitelline layer 
of the oocytes was removed with two forceps to expose the plasmamembrane. Membrane 
patches in the inside-out configuration were perfused with bath solutions containing (mM) 115 
K-MES, 5 KCl, 5 HEDTA, 10 HEPES (pH 7.0). The [Ca2+] in this solution was varied by adding 
CaCl2. The free [Ca2+] was first theoretically calculated with WEBMAXC v2.10 
(http://www.stanford.edu/~cpatton/maxc.html) and then measured using a Ca2+ electrode (WPI, 
Sarasota, FL). The borosilicate glass pipettes (WPI, Sarasota, FL) were filled with the bath 
solution at the lowest free [Ca2+]. The holding potential was 0 mV. Data were filtered to 1/5 of 
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the sampling frequency. G(V) curves for different BK clones (pWT, D364/367A, D894-898N) at 
different free [Ca2+]i were constructed as described above. Plotting Vhalf against [Ca2+] produced 
calibration curves for the three BK clones used. The free [Ca2+]i in the COVG experiments was 
then calculated, before and after caged Ca2+ release, by interpolating the GVhalf on the 
calibration curve of the corresponding clone. 
 
Model 
The statistical-mechanical model of BK channels presented in this thesis is based on the 
allosteric model implemented by Horrigan and Aldrich in 2002 (Horrigan and Aldrich, 2002) and 
expanded by our collaborator Dr. Daniel Sigg. It comprises a pore domain, four VSDs, four 
RCK1 Ca2+ sensors and four RCK2 Ca2+ sensors. The fitting of the model to the experimental 
data points was performed using the Berkeley Madonna software 
(www.berkeleymadonna.com/). 
The equations of the model are as follow: 
Equilibrium properties for the BK model are derived from the partition function Z, which can be 
expressed as a polynomial of equilibrium constants J, K1, K2, and L: 
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The activation numbers (j, k1, k2, and l) run from 0 to 4, with the exception of the pore number l, 
which has two values: 0 (closed) and 1 (open). 
The equilibrium constants are given by: 
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The partition factors Θjk1k2l are a function of both coupling constants (C1, C2, D, E1, E2, and F) 
and combinatorial factors. The value of Θ0000 is set to unity (consistent with the usual practice of 
setting the lowest activated state to zero energy). 
It is convenient to write the expression of Z in a hierarchical manner, starting with terms for the 
closed (C) and open (O) states of the channel, followed by distinctions between the voltage 
sensor J residing in the resting (R) or active (A) state, and finally subdividing between Ca2+-
binding of RCK1 and RCK2. Thus, 
Z = ZC4 + LZO4,  
where,    
ZC = ZCR + JZCA 
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ZO = ZOR + JDZOA 
and,   
ZCR = (1 + K1) + K2(1 + K1F), 
ZCA = (1 + K1E1) + K2E2(1 + K1E1F), 
ZOR = (1 + K1C1) + K2C2(1 + K1C1). 
ZOA = (1 + K1C1E1) + K2C2E2(1 + K1C1E1F). 
It should be noted that the last group of sub-partitions are voltage independent (functions of 
[Ca2+] only). We wish to know the mean number of activated domains AX as a function of Vm and 
[Ca2+]. The corresponding quantity for the J regulatory domain is: 
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with similar expressions for AK1, AK2, and AL. 
The relevant quantities for this paper are AJ (proportional to the fluorescence changes of the 
voltage sensor label) and AL (proportional to channel conductance). These are given by: 
ZLZAL /
4
O , 
 3OOA3CCA4 ZLDZZZZJAJ  . 
The normalized G(V) and F(V) are proportional to the activation curves of their respective 
regulatory domains: G(V) = AL; and F(V) = AJ/4. 
To obtain half-maximal voltage (GVhalf) of the G(V) curve, we set AL = 0.5,  from which we 
derive:  
L(ZOR + JDZOA)4  (ZCR + JZCA)4  = 0.  [condition for GVhalf]. 
From the voltage dependence of L and J given earlier in this supplement, one can 
numerically obtain the value GVhalf satisfying the above equation, which was done using the root 
finder algorithm in Berkeley Madonna. 
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Figure 38. Voltage dependent structural rearrangements of BK VSD. (A) Representative K+ 
current (black) and TMRM fluorescence (red) traces from oocytes expressing pWT channels. 
Pulse protocol is shown above recordings. (B) Averaged F(V) and G(V) curves for pWT 
channels. Data points are fitted to a single Boltzmann distribution and normalized to the 
respective maxima. Fitting parameters are: FVhalf= -80.87 mV; GVhalf= -4.69 mV. 
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2.C RESULTS 
The BK channel voltage sensor undergoes voltage-dependent 
structural changes that precede channel activation 
The human BK channel was engineered to allow for specific fluorescent labeling of the 
extracellular tip of the S4 transmembrane segment (pWT, see Methods), which is an important 
component of the BK VSD. After labeling the cysteine at position 202 with TMRM fluorophore, 
the oocytes were voltage-clamped using the Cut-open Oocyte Vaseline Gap (COVG) technique 
modified for epifluorescence measurement. K+ currents were recorded at different imposed 
membrane potentials. Simultaneously, TMRM fluorescence traces were acquired and a voltage 
dependent change of the fluorescence emission was detected (Figure 38). The voltage 
dependence of the fluorescence signal (F(V)) preceded the channel activation curve (G(V)) by ~ 
80 mV, as expected for protein rearrangement associated to the movement of the VSD. The half 
activation potentials (Vhalf) were FVhalf = -81.18 ± 2.80 mV and GVhalf = -4.07 ± 8.35 mV (n=4). 
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Ca2+ binding to the intracellular BK gating ring produces a structural 
change that propagates to the transmembrane VSD, as detected by 
voltage clamp fluorometry   
To study the Ca2+-induced conformational changes of BK VSD, Xenopus oocytes expressing 
pWT BK (prelabeled with TMRM) were injected with DM-Nitrophen, a caged Ca2+ compound 
that undergoes UV photolysis, releasing Ca2+. While under voltage clamp (using the COVG 
technique modified for epifluorescence measurement), we induced rapid increase of intracellular 
Ca2+ concentration ([Ca2+]i) by delivering UV flashes focused on the upper oocyte membrane. 
Simultaneous recordings of K+ currents and fluorescence emission from oocytes expressing 
pWT channels are shown in Figure 39A. Once the ionic current reached steady-state, the rapid 
increase of [Ca2+]i, triggered by the UV flash photolysis of DM-Nitrophen, increased the PO of BK 
channels, manifested as a downward or upward deflection in the ionic current traces for 
potentials above or below the K+ reversal potential, respectively. Notably, UV-induced Ca2+ 
uncaging also induced an increase of the simultaneously-recorded TMRM fluorescence 
emission (Figure 39A, red traces), suggesting that Ca2+ binding to the intracellular gating ring 
induces structural rearrangements in the transmembrane VSD.  
The voltage dependence of the fluorescence deflections (F(V)) and macroscopic K+ 
conductance (G(V)) were calculated from the fluorescence and ionic current recordings, 2 ms 
before and 10 ms after UV flashes (Figure 39B). The rapid increase in [Ca2+]i produced a 
hyperpolarizing shift of the G(V) curve (ΔGVhalf   ‐50 mV) associated with a smaller, but well-
resolved, translation of the F(V) curve in the same direction (ΔFVhalf   ‐25 mV).  Note that the 
Ca2+ release induced a cross-over of G(V) and F(V) curves (Figure 39B), evidence for BK 
channels undergoing conformational transitions while in the open state. This result is consistent 
with the established view that BK channels possess multiple open states sequentially populated 
during activation (Stefani et al., 1997; Horrigan and Aldrich, 2002; Magleby, 2003; Moczydlowski 
and Latorre, 1983).  
Ionic current and fluorescence traces from pWT BK channels expressed in oocytes not loaded 
with DM-Nitrophen were unaffected by UV flashes (Figure 39C). G(V) and F(V) curves 
calculated before and after UV-flashes were superimposed, underlining that the UV flash per se 
did not affect the properties of the recordings and the effects observed in oocytes injected with 
DM-Nitrophen were genuinely produced by Ca2+ (Figure 39D). 
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Figure 39. Intracellular Ca2+ photo-release induces conformational changes of the BK 
channel VSD. (A) K+ current and TMRM fluorescence traces simultaneously recorded during 
depolarizations to the indicated potentials from an oocyte expressing pWT channels and pre-
injected with DM-nitrophen are shown. UV-flashes were delivered onto the oocyte 60 ms 
after the onset of depolarization. [Ca2+]i increased from 10 μM to 84 μM. The photodiode 
amplifier was blanked for 3 ms during the UV flash to prevent overload. (B) Normalized 
fluorescence (F) and K+ conductance (G) data from the experiment in A, before and after UV 
flashes, were fit to a single Boltzmann distribution (before UV, GVhalf = 0 mV and FVhalf = -37 
mV; after UV, GVhalf = -51 mV and FVhalf = -63 mV). (C) As in A, but the oocyte was not pre-
injected with DM-nitrophen. (D) F(V) and G(V) curves were constructed before ([Ca2+]i= 8.2 
μM) and after ([Ca2+]i= 7.9 μM) UV flashes from the experiment in C and fitted to a single 
Boltzmann distribution (before UV, GVhalf = -10 mV and FVhalf = -75 mV; after UV, GVhalf = -10 
mV and FVhalf  = -76 mV). 
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Figure 40. RCK1 Ca2+ sensor impairment does not prevent VSD facilitation by Ca2+ release. 
(A) K+ current and TMRM fluorescence traces simultaneously recorded during 
depolarizations to the indicated potentials from an oocyte expressing BK channels with 
neutralized high-affinity Ca2+ sensing in RCK1 (D362A/D367A) and pre-injected with DM-
nitrophen are shown. UV-flashes were delivered onto the oocyte 35 ms after the onset of 
depolarization. [Ca2+]i increased from 137 μM to 320 μM. The photodiode amplifier was 
blanked for 3 ms during the UV flash to prevent overload. (B) Normalized fluorescence (F) 
and K+ conductance (G) data from the experiment in A, before and after UV flashes, were fit 
to a single Boltzmann distribution (before UV, GVhalf = -21 mV and FVhalf = -85 mV; after UV, 
GVhalf = -35 mV and FVhalf = -101 mV).  
The two high-affinity Ca2+ sensors of BK channels, in RCK1 and 
RCK2, are not functionally equivalent 
Two high-affinity Ca2+ sensors are located within the BK gating ring ligand-binding apparatus: 
one, in RCK1, includes residue D367, which is critical for Ca2+ sensing (Xia et al., 2002; Yusifov 
et al., 2010); the other, in the RCK2 domain, coordinates Ca2+ via the five Asp (D894-D898) 
comprising the Ca bowl (Yuan et al., 2010; Schreiber and Salkoff, 1997). 
To assess their respective contribution to the Ca2+-induced rearrangement of the VSD, the two 
high-affinity Ca2+ sensors were separately neutralized. The D362A/D367A mutations were 
introduced to impair high-affinity Ca2+ sensing in RCK1 (Xia et al., 2002). Following UV flash 
photolysis, the rapid increase of [Ca2+]i induced a shift towards more negative potentials in both 
the G(V) and F(V) curves, as observed in pWT channels although to a smaller extent (Figure 
40). This result suggests that an intact RCK1 Ca2+ sensor is not necessary to mediate the 
propagation of Ca2+-induced gating ring rearrangements to the VSD. 
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Figure 41. RCK2 Ca2+ sensor is necessary for VSD facilitation by Ca2+ release. (A) K+ 
current and TMRM fluorescence traces simultaneously recorded during depolarizations to 
the indicated potentials from an oocyte expressing BK channels with neutralized Ca bowl in 
RCK2 (D894-898N) and pre-injected with DM-nitrophen are shown. UV-flashes were 
delivered onto the oocyte 35 ms after the onset of depolarization. [Ca2+]i increased from 105 
μM to 210 μM. The photodiode amplifier was blanked for 3 ms during the UV flash to 
prevent overload. (B) Normalized fluorescence (F) and K+ conductance (G) data from the 
experiment in A, before and after UV flashes, were fit to a single Boltzmann distribution 
(before UV, GVhalf = 3 mV and FVhalf = -79 mV; after UV, GVhalf = -26 mV and FVhalf = -78 
mV).  
Conversely, when the Asp in the Ca bowl (in RCK2) were mutated into Asn (D894-898N) 
(Schreiber and Salkoff, 1997), intracellular Ca2+ release no longer induced the F(V) curve shift 
(Figure 41). Still, the PO of this mutant was increased by the elevation of [Ca2+]i, demonstrated 
by the leftward-shifted G(V) curve following Ca2+ release (Figure 41B). Incidentally, the absence 
of a change in VSD fluorescence excludes the possibility of a direct effect (e.g., charge 
screening) of Ca2+ on the BK VSD. This also shows that TMRM fluorescence was not perturbed 
by the Ca2+-dependent motions of the pore. These experiments point to the view that there is a 
functional coupling between RCK2 Ca2+ sensor and the VSD, and that no such link exists 
between RCK1 Ca2+ sensor and the VSD. 
 
Results from all experiments performed are shown in Figure 42. The Ca2+-induced shift of the 
half-activation potential of G(V) curves (ΔGVhalf) was consistently associated with a shift of the 
F(V) curves (ΔFVhalf) in the same direction, but only in BK channels with an intact Ca bowl 
(Figure 42). To quantify the dependence of observed shifts in G(V) and F(V) curves on Ca-
release in pWT and mutants channels, we performed a statistical analysis (see Methods). A 
strong monotonic correlation between Ca2+ release (ΔkTln[Ca2+]) and G(V) and F(V) voltage 
shifts was found in pWT and in the D362A/D367A mutant (Figure 43A&B). This was also true for 
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Figure 42. The Ca bowl is required for the Ca2+-mediated effect on VSD movements. The 
plot shows the shifts in GVhalf (ΔGVhalf) and FVhalf (ΔFVhalf) measured in response to calcium 
release for all the experiments performed. 
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Figure 43. Set of experiments measuring shifts in GVhalf and FVhalf in response to calcium 
release. (A, B, C) These plots show the changes in activation energy produced by Ca2+ 
photo-release (zL*ΔGVhalf and 4zJ*ΔFVhalf) plotted against the chemical potential ΔkTln[Ca2+]. 
A strong monotonic correlation exists between Ca-release and G(V) and F(V) voltage shifts 
in pWT (A) (zL*GVhalf: ρ = -1.0, P<0.001; 4zJ*FVhalf: ρ = -0.915, P<0.001) and in the 
D362A/D367A mutant (B) (zL*GVhalf: ρ = -0.868, P < 0.001; 4zJ*FVhalf: ρ = -0.787, P=0.002). 
This is also true for the D894-898N mutant (C) in the case of zL*ΔGVhalf (ρ = -0.970, 
P<0.001), but not in the case of 4zJ*ΔFVhalf (ρ = 0.146, P=0.705).  
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the D894-898N mutant in the case of zL*GVhalf (P<0.001), but not in the case of 4zJ*ΔF-Vhalf 
(P=0.705) (Figure 43C). Thus, with the exception of the RCK2 mutant, an  increase in 
intracellular [Ca2+] consistently produced a leftward shift in the activation curves (ΔGVhalf) 
associated with a statistically-significant shift of the voltage sensor activation (ΔFVhalf) in the 
same direction. 
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Figure 44. The dependence of GVhalf vs. free [Ca2+]i when the two BK Ca2+ sensors are 
alternatively neutralized. (A) Representative K+ current traces were recorded from excised 
patches of Xenopus oocytes in the inside-out configuration expressing pWT, neutralized 
RCK1 (D362A/D367A) or neutralized RCK2 (D894-898N) channels at free [Ca2+]i = 22 μM. 
The voltage protocol is shown above the traces. (B) Normalized G(V) curves from the 
experiments in A were fit to Boltzmann distributions (lines) to estimate their half activation 
potential (GVhalf). (C) Mean GVhalf vs. free [Ca2+]i plot was constructed from the G(V) curves 
calculated at different [Ca2+]i ranging from 0.72 to 830 μM. 
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BK channels as intrinsic sensor of [Ca2+] at the plamsamembrane 
level 
In order to estimate local intracellular free [Ca2+]i before and after UV photolysis, we took 
advantage of the BK intrinsic Ca2+-sensing properties, as previously reported in motor neurons 
and hair cells (Sun et al., 2004; Sy et al., 2010). BK channels were expressed in Xenopus 
oocytes. Patch-clamp experiments were performed in the inside-out configuration. This 
technique allowed the control and exchange of the solution facing the intracellular portion of the 
channel where the two Ca2+ sensors are located. Solutions at different free [Ca2+]i, ranging 
between ~1 μM and ~1 mM, were perfused on the excised patch and ionic currents at different 
potentials were recorded (Figure 44). G(V) curves for different BK clones (pWT, D364/367A, 
D894-898N) were constructed at each [Ca2+]i (Figure 44B). The midpoints of these curves 
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Figure 45. Schematic representation 
of the allosteric model for BK channel 
activation. It includes a pore domain 
and three regulatory domains: the 
VSD and two Ca2+-sensing domains 
(RCK1 and RCK2) per subunit. The 
pore transitions between closed (C) 
and open (O) states according to the 
equilibrium constant L; the VSD can 
be found either in the resting (R) or 
active (A) state according to 
equilibrium constant J; Ca2+ sensors 
can exist in unbound or Ca2+-bound 
states according to equilibrium 
constants K1 and K2.  D, C1, C2, E1, 
E2 and F are allosteric factors. 
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(GVhalf) were plotted versus [Ca2+] to produce calibration curves for the three BK clones used in 
the Ca-release experiments (Figure 44C). As expected, when one of the two high-affinity Ca2+ 
sensors was impaired, a larger depolarization was necessary to achieve the same degree of 
channel activation, in agreement with the effects previously observed in WT BK channels 
(Schreiber and Salkoff, 1997; Xia et al., 2002).The GVhalf vs [Ca2+] plot was used to estimate 
[Ca2+]i in the Ca-release experiments by interpolating the GVhalf before and after UV flashes. 
These estimated [Ca2+]i were fed into the BK channel model as described in the next section. 
 
A BK channel allosteric model with two high-affinity Ca2+ sensors and 
one voltage sensor per subunit 
To quantify the mechanistic interpretation of the 
experimental results, we fit the data with an 
allosteric statistical-mechanical model inspired by 
the seminal Horrigan and Aldrich (HA) model of BK 
channel activation at steady-state (Horrigan and 
Aldrich, 2002). The HA model describes the 
allosteric interactions linking voltage sensing, Ca2+ 
binding and pore opening in BK channels.  Since 
results from the Ca2+ photo-release experiments 
suggest that RCK1 and RCK2 Ca2+ sensors employ 
different allosteric pathways to produce Ca2+-
mediated activation, we expanded on the HA model 
to include two Ca2+-sensing domains (Figure 45). In 
this model, each Ca2+ sensor is capable of 
interacting with the Pore (allosteric factors C1 and 
C2), with the VSD (allosteric factors E1 and E2) and 
each other (allosteric factor F). 
Data points (normalized G(V) and F(V) curves) from 
representative experiments of the three BK channel 
clones (pWT, RCK1 and RCK2 mutants), each at 
two Ca2+ concentrations (before and after UV 
photolysis), were simultaneously fit by the model: 
F(V) data were fit to the model prediction of VSD 
activation while G(V) data were fit with PO. As a 
further constraint, we simultaneously fit averaged 
values of GVhalf as a function of [Ca2+] for the three 
BK channel clones (Figure 45). In fitting the mutant 
channels, we minimized the number of changing 
parameters needed to obtain good fits, while 
constraining the remaining variables to their pWT 
equivalent. Since it appears that RCK1 retains its 
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Figure 46. The allosteric model for BK channel activation fits experimental data from three 
different BK channel mutants. The experimental GV and FV data for pWT (A), RCK1 mutant 
D362A/D367A (B) and RCK2 mutant  D894-898N (C)  were fitted simultaneously together 
with the data points describing the [Ca2+] dependence of the GVhalf . Continuous lines are the 
prediction of the BK allosteric model while experimental data points are as in Figures 39B, 
40B, 41B, 44C.  
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high-affinity Ca2+-binding properties when D362/D367 are neutralized (Yusifov et al., 2010), Kd1 
in the RCK1 mutant was constrained to be equal to the corresponding pWT value. Inter-subunit 
interactions between BK regulatory domains were not included: single-channel studies indicated 
that such interactions do not play a major role (Niu and Magleby, 2002).  [Ca2+]i was estimated 
by interpolating the GVhalf value in the plot in Figure 44C, taking advantage of BK intrinsic ability 
to report [Ca2+]i at the membrane level. 
The model parameters that best account for the data are listed in Table 1.  The valence of the 
VSD charge is zJ = 0.6 e0; the opening of the channel (C-O transition) is also intrinsically 
voltage-dependent (zL = 1 e0), in agreement with previous works (Horrigan and Aldrich, 2002; 
Ma et al., 2006). During the simultaneous fitting (Figure 46A), the intrinsic Ca2+ dissociation 
constants for RCK1 (Kd1) and RCK2 (Kd2) were constrained to the range reported by a recent 
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study  (Sweet and Cox, 2008), resulting in Kd1 = 10.03 μM and Kd2 = 2.98 μM for pWT 
channels. We also found that, in the Ca2+-bound state, RCK1 strongly stabilized VSD activation 
(E1 = 10) and, to a lesser extent, the conducting state (C1 = 2.84). On the other hand, RCK2 
efficiently facilitated pore operation (C2 = 10.41) and exerted a positive cooperativity on VSD 
activation (E2 = 2.28). A negative cooperativity was exhibited between the two Ca2+-sensing 
domains (F = 0.02), as also suggested by a previous investigation (Sweet and Cox, 2008). In 
the RCK1 mutant channels (Figure 46B), D362/367A mutations abolished the RCK1-Pore 
cooperativity (C1 = 1) and slightly affected the allosteric factor F (from 0.02 to 0.06), leaving 
unaltered the RCK1-VSD interaction. In agreement with the consolidated knowledge that the 
neutralization of the Ca bowl (D894-898N) impairs high-affinity Ca2+-sensing (Yusifov et al., 
2010), the model predicted a marked increase in Kd2 in the D894-898N mutant (Kd2 = 4820 μM) 
(Figure 46C). The allosteric interaction RCK2-Pore (C2) did not vary compared to the pWT 
channel. Instead, a negative cooperativity was found between RCK2 and VSD (E2 = 0.7). In 
addition, RCK1-RCK2 interaction becomes stronger (F = 11.6). 
Table 1. Fitting parameters (for the mutants only parameters different from pWT are reported). 
Parameters Ca2+-sensing mutations 
Domain or Interaction pWT D362/367A D894-898N 
Pore 
zL (e0) 1.00 
VL (mV) 307 
S4 
zJ (e0) 0.60 
VJ (mV) 20 
RCK1 Kd1 (M) 10.03 
RCK2 Kd2 (M) 2.98 4820 
S4-Pore D 3.34 
RCK1-Pore C1 2.84 1.00 
RCK1-S4 E1 10.00 
RCK2-Pore C2 10.41 
RCK2-S4 E2 2.28 0.70 
RCK1-RCK2 F 0.02 0.06 11.60 
 
63 
 
2.D DISCUSSION 
BK channels integrate properties of both voltage- and ligand-gated ion channels, a feature that 
allows them to achieve the fine task of coupling the membrane potential with [Ca2+]i to control 
key physiological processes such as smooth muscle tone, cochlear hair cell tuning, neuronal 
excitability, neurotransmitter release, insulin secretion, and oxygen sensing (Fettiplace and 
Fuchs, 1999; Hu et al., 2001; Salkoff et al., 2006; Braun et al., 2008; Wu and Marx, 2010). The 
interaction between voltage- and Ca2+-sensing mechanisms was proposed for native BK 
channels reconstituted in lipid bilayer (Moczydlowski and Latorre, 1983) and further investigated 
in cloned BK channels, demonstrating the allosteric nature of the dual activation mechanism, 
synergistically facilitating channel gating (Horrigan and Aldrich, 2002; Horrigan, 2012; Magleby, 
2003; Cui et al., 2009; Sweet and Cox, 2008). To investigate how the Ca2+-induced 
conformational changes of the gating ring at the intracellular portion of the channel can 
propagate to, and be resolved as, structural rearrangements of the VSD, the voltage-clamp 
fluorometry technique (Mannuzzu et al., 1996; Cha and Bezanilla, 1997; Gandhi and Olcese, 
2008) was combined with the UV-photolysis of a Ca2+ cage compound, DM-Nitrophen (Escobar 
et al., 1997; Ellis-Davies, 2003), to simultaneously trigger the voltage- and Ca2+-dependent 
activations of BK channels. 
The intracellular region of BK channels encompasses two high-affinity Ca2+ sensors per subunit 
(one in RCK1 and one in RCK2 domains). The RCK1 and RCK2 domains are structurally similar 
(Yusifov et al., 2008; Yusifov et al., 2010; Yuan et al., 2010; Yuan et al., 2011; Wu et al., 2010) 
and assemble into the ligand-sensitive gating ring complex. However, they share little primary 
sequence homology (<25%) and are not topologically equivalent within the gating ring super-
structure. These underlying differences could account for their apparent functional discrepancy. 
In fact, their Ca2+-sensing sites differ in several respects, including: structure and relative 
positions within the gating ring and RCK domains (Figure 29) (Wu et al., 2010; Yuan et al., 
2010; Yuan et al., 2011); affinity and selectivity for divalent cations (Zeng et al., 2005); apparent 
voltage dependence of Ca2+-binding (Sweet and Cox, 2008); and role in epilepsy/dyskinesia-
causing BK channel mutants (Yang et al., 2010). Given these established differences, do the 
two high-affinity Ca2+ sensors also exert different contributions to the pore and VSD activations? 
In pWT BK channels, the rapid increase of [Ca2+]i by UV-photolysis of DM-Nitrophen induces a 
conformational change that, originating in the gating ring upon Ca2+-binding,  propagates to the 
VSD, facilitating its activation (Figure 39). Indeed, the purified BK gating ring in solution can 
undergo Ca2+-driven structural rearrangements resulting in an overall decrease of its 
hydrodynamic radius (Javaherian et al., 2011). To understand the contribution of each Ca2+ 
sensor, they have been alternatively neutralized such that only one at the time is functional in 
the BK channel. The impairment of Ca2+ sensing in RCK2 (Ca bowl neutralization), but not in 
RCK1, abolishes the effect of the [Ca2+]i elevation on VSD activation, underlining a functional 
difference of the two Ca2+ sensors. 
Using a statistical-mechanical model inspired by the HA model (Horrigan and Aldrich, 2002), but 
accounting for two distinct Ca2+ sensors (Figure 45), we quantified the allosteric interactions 
between pore, VSD and the two RCK domains. In pWT channels, the model predicts salient 
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differences in the allosteric coupling between RCK1 and RCK2 with the VSD and the pore 
(Table 1), suggesting that they are functionally separable, in spite of their structural homology. 
RCK1 and RCK2 are allosterically coupled by negative cooperativity, such that the activation of 
one domain disfavors the activation of the other, recapitulating the findings of Sweet & Cox 
(Sweet and Cox, 2008). The functional impairment of Ca2+ sensing either in RCK1 or in RCK2 
highlights their functional diversity. In D362A/D367A mutants, a rapid increase in [Ca2+]i 
significantly facilitates pore and VSD activation (Figure 40), as indicated by the consistent 
leftward shifts of both G(V) and F(V) curves at the highest [Ca2+]i. This effect is likely mediated 
by intact Ca bowls in RCK2 domains. In the model, the effect of the D362A/D367A mutations is 
mostly accounted by the loss of cooperativity between RCK1 and the pore (allosteric factor C1) 
(Table 1). It is interesting that the model can predict the effects of the D362A/D367A mutations 
without reducing the intrinsic Ca2+ affinity of the RCK1 domain (Kd1). This prediction would be in 
agreement with the lack of direct experimental evidence that D362/D367 residues are essential 
for Ca2+ coordination. However, a potential Ca2+-binding site involving D367 and other residues 
has been proposed based on electrophysiological evidence (Xia et al., 2002) and inference from 
the gating ring crystal structure (Zhang et al., 2010). Conversely, the neutralization of the Ca 
bowl abolishes the Ca2+-induced facilitation of the VSD activation: indeed, the F(V) curves were 
not significantly modified by the Ca2+ release (Figure 41B, 42). To account for these 
experimental data, three model parameters are considerably altered compared to the 
corresponding pWT values (Table 1), suggesting that the neutralization of the five Asps not only 
abolishes a high-affinity Ca2+-binding site (Ca bowl) but also alters the energetics of gating ring 
operation, likely because of a structural perturbation. 
Recent work has pointed out an important functional difference between RCK1 and RCK2: Ca2+-
binding to the RCK1 domain (but not to RCK2) is voltage-dependent (Sweet and Cox, 2008). To 
test the validity of our model prediction, we computed the steady-state occupancy of the Ca2+-
bound state for RCK1 and RCK2. For a wide range of membrane potentials, the occupancy of 
RCK1 Ca2+-bound state is voltage-dependent, while RCK2 Ca2+-binding is weakly affected by 
membrane potential (Figure 47). Thus, in spite of their structural homology, RCK1 and RCK2 
domains provide different contribution to the Ca2+-dependent activation of BK channels.  
The precise structural basis of the model energetic couplings is as yet unknown. It is possible to 
speculate that the S6-RCK1 linker, which operates like a spring, connecting the gating ring with 
the channel pore functionally as well as structurally (Niu et al., 2004), could account for the 
allosteric factor C1; Mg2+ dynamically coordinated between RCK1 and S4 (Horrigan and Hoshi, 
2008; Yang et al., 2008; Chen et al., 2010) could mediate the allosteric factor E1; in addition, 
hydrophobic residues between RCK1 and RCK2 (Kim et al., 2006) and properties of the RCK1-
RCK2 linker (Lee et al., 2009) could contribute to the allosteric factor F. Mutations in the critical 
Ca2+-sensing sites of RCK1 and RCK2, in some cases, result in stronger interactions between 
channel domains (Table 1), even though Ca2+ sensitivity and channel activation are impaired. It 
is possible that these mutations not only impair Ca2+ binding, but also could cause subtle 
structural alterations, which would in turn perturb the free energy transduction to distal 
regulatory domains. 
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Figure 47. Model predictions of the voltage dependence of the Ca2+-bound state of RCK1 
and RCK2. The plots show the steady-state occupancy of the Ca2+-bound state for RCK1 
(A) in the D894-898N BK channel and for RCK2 (B) in the  D362A/D367A BK channels, as 
predicted by the model. For a wide range of membrane potentials (grey background), Ca2+ 
binding is strongly voltage-dependent in RCK1 domain (A), but weakly in RCK2 domain (B). 
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The importance of achieving deeper understanding of BK channel biophysical properties resides 
in its involvement in several diseases, such as hypertension, epilepsy, schizophrenia and 
diabetes (Yang et al., 2010; Grimm and Sansom, 2010; Braun et al., 2008). In particular, 
elucidating the mechanisms underlying the functional coupling between VSD and the two 
distinct Ca2+ sensors is fundamental for the physiology and pathophysiology of excitable cells. 
For instance, the Slo1 epilepsy/dyskinesia-causing mutation affects Ca2+-dependent activation 
originating from the Ca2+-binding site in RCK1, but not in RCK2, by altering the coupling 
mechanism between Ca2+ binding and gate opening (Yang et al., 2010). 
In summary, the allosteric nature of BK channel Ca2+-dependent activation has been directly 
probed by optically tracking VSD movements perturbed by Ca2+-binding to the gating ring, under 
voltage clamp. By investigating channels impaired in high-affinity Ca2+-sensing sites, it is 
unraveled that the two BK Ca2+ sensors are not functionally equivalent: although both contribute 
to Ca2+-dependent channel activation, the efficiency of the allosteric interactions appears 
different. A functional Ca Bowl (RCK2) is required to observe the propagation of Ca2+-induced 
“wave” of rearrangements from the cytoplasmic portion to the transmembrane VSD. The results 
are fit with a statistical-mechanical allosteric model to quantify the cooperative interactions 
among the prominent BK regulatory domains.  
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